GABA

PubMed ID: 21677899

Gabapentin enacarbil significantly improved restless legs severity and sleep vs placebo — directly supports reduced motor restlessness (drug is GABAergic prodrug; indirect relevance).

PubMed ID: 21350425

Pantogam add-on reduced anxiety measures and improved QoL — direct support for reduced nervousness.

PubMed ID: 26978493

Pantogam activ produced rapid anxiolytic effects in hypertensive patients.

PubMed ID: 1678735

Metadoxine helped control alcohol withdrawal with reduced benzodiazepine need — clinically relevant stress/anxiety control in withdrawal.

PubMed ID: 8261880

Baclofen produced clear reductions in anxiety/depression in clinical trial (direct stress-reduction evidence).

PubMed ID: 11123486

Baclofen improved mental symptoms during opiate withdrawal (reduced psychological distress/nervousness).

PubMed ID: 12217947

Baclofen decreased state anxiety and craving in alcohol-dependent patients (strong support for reducing nervousness).

PubMed ID: 16841627

Pregabalin produced significant and rapid anxiety symptom reductions—strong evidence for stress reduction.

PubMed ID: 16490478

Baclofen reduced alcohol withdrawal symptoms comparably to diazepam, indicating reduced withdrawal‑related stress.

PubMed ID: 17178181

Gabapentin increased subjective vigour in early alcohol withdrawal—suggests steadier, less fraught energy.

PubMed ID: 18068515

Baclofen increased abstinence and improved outcomes in alcohol dependence, which likely reduces stress/craving.

PubMed ID: 18855801

Gabapentin reduced cue‑elicited arousal and craving in alcohol‑dependent volunteers — clear anxiolytic/calmness signal and improved sleep.

PubMed ID: 21456104

Pregabalin significantly reduced HAM‑A anxiety scores vs placebo — direct evidence for reducing nervousness.

PubMed ID: 19485969

Gabapentin reduced withdrawal severity and treatment‑period anxiety/craving vs lorazepam in outpatient AWS trial.

PubMed ID: 19935070

Preop gabapentin reduced early postoperative pain and opioid need — reduces muscular/physical tension post‑op.

PubMed ID: 20825805

Phenobarbital and lorazepam (GABAergic) were effective for alcohol withdrawal — clinical calming efficacy.

PubMed ID: 22710530

Gabapentin+esmolol blunted laryngoscopy/intubation cardiovascular stress spikes.

PubMed ID: 21454917

Gabapentin added to naltrexone reduced heavy drinking and improved sleep — likely reduces stress in early recovery.

PubMed ID: 21990176

Baclofen substantially lowered need for high‑dose benzodiazepines and improved withdrawal control — reduces restlessness in AWS.

PubMed ID: 22302014

Pregabalin significantly reduced anxiety (HAM‑A) in GAD—direct evidence for lowering stress/anxiety.

PubMed ID: 24190578

Gabapentin improved sleep and craving and reduced depressive symptoms—consistent with greater calm/less agitation.

PubMed ID: 26048580

High‑dose baclofen increased abstinence (one RCT), which can reduce stress related to heavy drinking; supportive though indirect.

PubMed ID: 27808555

Baclofen reduced craving/anxiety and increased abstinence days (open-label RCT).

PubMed ID: 26659543

GHB produced dose-related sedation in healthy men (PK/PD study).

PubMed ID: 28440812

Baclofen lowered heart rate and changed subjective effects in anxious alcohol‑dependent subjects — physiologic sign of increased calmness.

PubMed ID: 29278929

Preoperative gabapentin greatly reduced catheter‑related bladder discomfort and rescue analgesic use — strong reduction in physical discomfort/tension.

PubMed ID: 29665351

Baclofen altered cortisol/ACTH and other stress‑related hormones in alcohol‑dependent subjects — supports anti‑stress effects.

PubMed ID: 30217552

Baclofen reduced alcohol‑cue brain activation and connectivity (neural correlate of cue‑elicited stress/craving) and was associated with abstinence.

PubMed ID: 30821824

Perioperative gabapentin lowered probability of a high‑pain acute trajectory — supports reduced acute postoperative tension/pain.

PubMed ID: 32518932

Single 600 mg gabapentin preop significantly reduced early postoperative pain, analgesic needs and CRBD — clinically meaningful reduction of tension/discomfort.

PubMed ID: 33338971

Alprazolam (GABA‑A agonist) blunted cortisol response to stress in healthy men — demonstrates that GABAergic modulation can reduce stress physiology (relevant mechanism).

PubMed ID: 33620407

Baclofen modestly reduced agitation events in ventilated ICU patients—direct, objective evidence of reduced motor/behavioral restlessness.

PubMed ID: 34155332

Baclofen 90 mg/day showed anxiolytic benefit in higher-anxiety subgroup and reduced heavy drinking—clinically meaningful calmness signal.

PubMed ID: 36084413

Diary analysis suggests baclofen abolished a strong stress–drinking association in women—evidence for stress modulation.

PubMed ID: 37526038

Baclofen in detox reduced need for diazepam and likely reduced withdrawal-related restlessness/anxiety during detoxification.

PubMed ID: 39043077

Pregabalin reduced acute pain scores in a randomized trial — pain/tension reduction plausible.

PubMed ID: 38828963

Gabapentin reduced insomnia and is used to treat anxiety/withdrawal symptoms in some contexts.

PubMed ID: 40760644

TEAS reduced HAMA scores dramatically and increased serum GABA — strong evidence for reduced nervousness.

PubMed ID: 20711135

Gabapentin+alpha‑lipoic acid produced large symptom relief in burning mouth syndrome — strong reduction in painful tension symptoms.

PubMed ID: 1998451

Oral baclofen improved leg spasticity in MS patients (objective measures), indicating reduced muscle tension.

PubMed ID: 8421205

Large multicenter study: chronic intrathecal baclofen decreased Ashworth rigidity score by −2.2 points and reduced spasms markedly.

PubMed ID: 8788983

Baclofen produced affective improvement in alcoholic patients, consistent with greater calmness.

PubMed ID: 8751632

Implanted intrathecal baclofen produced large reductions in Ashworth rigidity and spasm frequency—strong muscle/tension relief.

PubMed ID: 9450156

Pivagabine reduced anxiety scores in climacteric women (controlled trial).

PubMed ID: 9450159

Pivagabine reduced fatigability and improved neurasthenic symptoms (less restlessness likely).

PubMed ID: 9450160

Pivagabine reduced sleep disturbances and improved diurnal behaviour/attention in children (randomized).

PubMed ID: 9846778

Gabapentin improved sleep and mood measures in neuropathic pain, consistent with stress reduction.

PubMed ID: 9846777

Gabapentin improved pain and sleep in diabetic neuropathy—can reduce physical tension from pain.

PubMed ID: 10372564

Mood/interpersonal adjustment gains can include reduced anxiety/nervousness.

PubMed ID: 10440462

Randomized, placebo-controlled trial showed gabapentin significantly reduced social phobia symptoms (direct evidence of easier social calm).

PubMed ID: 10565592

Vigabatrin reduced infantile spasms by 78% in RCT — robust reduction in pathologic motor restlessness (spasms).

PubMed ID: 9924905

Dose-related seizure reductions with vigabatrin decrease involuntary motor events that relate to restlessness.

PubMed ID: 10666558

Midazolam (GABA-A modulator) produced strong sedation and impaired memory — robust evidence that GABAergic agonism induces calm/sedation (drug context).

PubMed ID: 10695888

Long-term intrathecal baclofen markedly lowered spasticity (Ashworth scores) for years—clear reduction in muscular tension.

PubMed ID: 12611835

Short‑term pregabalin reduced anxiety scores versus placebo.

PubMed ID: 12826986

Pregabalin 600 mg/day significantly reduced anxiety with quick onset—strong reduction in nervousness.

PubMed ID: 15087630

Preoperative gabapentin substantially reduced pain and opioid use, lowering nociceptive tension.

PubMed ID: 15206660

Pregabalin reduced LSAS scores in social anxiety disorder, directly supporting easier social calm.

PubMed ID: 16416358

Long‑term pain relief with gabapentin lowers chronic tension.

PubMed ID: 15818684

Fibromyalgia pain reductions and better sleep reduce muscular/tension symptoms.

PubMed ID: 16143734

Large GAD trial with substantial reductions in psychic anxiety and nervousness.

PubMed ID: 15710092

Gabapentin improved spasticity (Ashworth scores), consistent with reduced muscular tension.

PubMed ID: 15845693

Preoperative gabapentin markedly lowered preop anxiety VAS, consistent with stress reduction.

PubMed ID: 16244006

Multimodal gabapentin regimen reduced acute and chronic pain, likely lowering patient stress levels.

PubMed ID: 15738746

Pregabalin produced large, rapid reductions in HAM‑A anxiety scores (directly reduces nervousness).

PubMed ID: 16466610

Pregabalin improved sleep and reduced neuropathic pain; anxiety/sleep improvements support increased calmness.

PubMed ID: 17030096

Gabapentin roughly halved jaw-muscle pain and greatly reduced muscle hypersensitivity—supports reduced muscular tension.

PubMed ID: 17130411

Pregabalin improved anxiety measures in central neuropathic pain patients—direct support for reduced nervousness.

PubMed ID: 16595614

Perioperative gabapentin attenuated hemodynamic stress responses to intubation (systolic/diastolic blood pressure reductions).

PubMed ID: 17146104

Gabapentin reduced hot flashes substantially — reducing a common physiologic stressor and associated distress.

PubMed ID: 16805934

Gabapentin blunted hemodynamic (stress) responses to intubation — physiologic stress reduction.

PubMed ID: 17631400

Pain and sleep improvements with pregabalin likely reduce stress associated with neuropathic pain.

PubMed ID: 18090504

Pregabalin reduced relapse in GAD — supports longer-term maintenance of calm/anxiety control.

PubMed ID: 18978320

Pregabalin reduced anxiety symptoms in older adults with GAD; less nervousness is a core component of effect.

PubMed ID: 18635690

Pregabalin reduced dental-anxiety in an experimental model, demonstrating acute reduction in nervousness.

PubMed ID: 19458926

Baclofen (GABA‑B agonist) and eperisone improved spasticity measures and electrophysiology—direct muscle/tone effects.

PubMed ID: 19188575

Gabapentin‑enacarbil produced large reductions in RLS severity and high responder rates—strong evidence for reduced restlessness.

PubMed ID: 19667976

Gabapentin enacarbil produced large, dose-dependent improvement in restless legs severity (direct, high-quality RCT evidence).

PubMed ID: 19583071

Gabapentin premedication blunted physiologic stress responses to intubation (HR/BP).

PubMed ID: 19534799

Pregabalin improved sleep quality in large trials, consistent with increased calm/relaxation.

PubMed ID: 19410509

Pregabalin produced direct sleep and relaxation benefits in fibromyalgia trials.

PubMed ID: 19921480

Pregabalin+celecoxib yielded large pain reductions in chronic low back pain — tension reduction expected.

PubMed ID: 19238802

Gabapentin prodrug produced large reductions in RLS severity and objective improvements in sleep architecture.

PubMed ID: 19798503

Real‑world pregabalin use produced broad improvements in sleep and mood consistent with greater calmness.

PubMed ID: 19825903

Single preoperative 300 mg pregabalin substantially lowered preop anxiety (nervousness) VAS.

PubMed ID: 19587470

Baclofen formulations reduced muscle tone/spasm (Ashworth score) — clear reduction in muscular tension.

PubMed ID: 20722471

Yoga increased thalamic GABA and correlated with reduced anxiety (less nervousness).

PubMed ID: 20427750

Pregabalin significantly improved RLS severity and reduced periodic limb movements (objective reduction in restlessness).

PubMed ID: 20511481

Gabapentin enacarbil maintenance markedly lowered relapse of RLS symptoms versus placebo.

PubMed ID: 20347225

Meta-analysis: pain reduction often accompanied by reduced stress and improved mood/function.

PubMed ID: 20466589

Dose-ranging pregabalin trial produced dose-dependent reductions in restless legs symptoms—direct evidence for reduced restlessness.

PubMed ID: 21388079

Preoperative gabapentin markedly lowered anxiety VAS — direct evidence for less nervousness.

PubMed ID: 21734588

Pregabalin maintenance in generalized social anxiety disorder delayed relapse and maintained symptomatic improvement — supports continued social calm (indirect).

PubMed ID: 21965636

Pregabalin in fibromyalgia reduced pain and FIQ, which can relieve muscular tension symptomatically.

PubMed ID: 21397402

Sodium oxybate improved sleep disturbance and fatigue in fibromyalgia; may reduce subjective restlessness at night.

PubMed ID: 21818576

Preemptive gabapentin 600 mg reduced postoperative pain and opioid use after hysterectomy, indirectly reducing tension.

PubMed ID: 21368587

Large RCT: pregabalin 600 mg produced large reductions on the Liebowitz Social Anxiety Scale — strong evidence for easier social calm (prescription GABA analogue; indirect to dietary GABA).

PubMed ID: 21611981

Gabapentin enacarbil reduced periodic limb movements with arousal and wake time, directly reducing nocturnal restlessness.

PubMed ID: 21316855

Pregabalin improved HADS‑A anxiety scores in a randomized trial, indicating reduced stress.

PubMed ID: 20479668

Perioperative gabapentin attenuated sympathetic/hemodynamic spikes — physiologic reduction in acute stress response.

PubMed ID: 21242741

Long-term gabapentin enacarbil substantially improved RLS symptoms — direct reduction of restlessness.

PubMed ID: 22203366

Oral GABA attenuated stress-related EEG changes and improved mood during mental tasks.

PubMed ID: 21693549

Pregabalin lowered HAM-A scores and withdrawal severity in benzodiazepine tapering — less nervousness.

PubMed ID: 23053645

Large RCT showed gabapentin reduced state anxiety in breast cancer survivors — robust stress reduction signal.

PubMed ID: 22664749

Once-daily gabapentin enacarbil reduced RLS severity and global ratings vs placebo.

PubMed ID: 22497967

G‑GR gabapentin reduced neuropathic pain and sleep interference—decreased nocturnal discomfort that contributes to restlessness.

PubMed ID: 23121149

Gabapentin enacarbil reduced RLS severity in a large RCT—direct and strong evidence for reduced nocturnal restlessness.

PubMed ID: 23089176

Pregabalin greatly reduced moderate‑to‑severe post‑burn itch (a driver of restlessness) versus antihistamines/placebo.

PubMed ID: 22993294

Arbaclofen produced post‑hoc improvements in social avoidance in fragile X syndrome—direct signal for improved social calm in some patients.

PubMed ID: 22373942

Gabapentin reduced cannabis withdrawal symptoms (including restlessness) and decreased use—supports lower restlessness in that setting.

PubMed ID: 23223108

Intrathecal baclofen reduced pain types and dystonia in CRPS—reduces muscular/neuropathic tension and symptom burden.

PubMed ID: 22045156

Pregabalin reduced postoperative pain and opioid requirements after spinal surgery—less pain/stress during recovery.

PubMed ID: 23006968

Ningdong granule increased serum GABA and significantly reduced tics in Tourette patients — direct reduction of motor restlessness (herbal formula but GABA increase shown).

PubMed ID: 22309784

Preoperative gabapentin markedly reduced catheter‑related bladder discomfort incidence/severity — decreases a source of postoperative discomfort/tension.

PubMed ID: 22770920

Preoperative gabapentin significantly lowered state anxiety measures (direct reduction in nervousness).

PubMed ID: 22929636

Single‑dose gabapentin attenuated haemodynamic and cortisol stress responses during pneumoperitoneum (objective reduction in physiological stress markers).

PubMed ID: 24347765

Gabapentin decreased anxiety during retrobulbar block (situational reduction in nervousness).

PubMed ID: 23377862

Single 1,200 mg gabapentin significantly reduced preoperative anxiety and catastrophizing — directly reduces nervousness in that context.

PubMed ID: 23620421

Gabapentin premedication reduced subjective anxiety in elderly cataract patients compared with diazepam.

PubMed ID: 23865122

Gabapentin substantially lowered migraine frequency/severity/duration — clear reduction of headache‑related tension.

PubMed ID: 23998397

Pooled pregabalin trials reduced neuropathic pain and increased responder rates — evidence for decreased ongoing somatic tension.

PubMed ID: 23582109

Baclofen produced a modest, significant reduction in lower‑limb spasticity (reduction in muscle tension) in MS patients (comparative trial vs TENS).

PubMed ID: 23428122

Oral GABA lowered plasma substance P (associated with pain/tension) in children with asthma — biochemical support for reduced tension.

PubMed ID: 24264551

Preoperative gabapentin reduced emergence agitation in children — directly lowered acute post‑anesthetic nervous/agitated behavior.

PubMed ID: 24968500

Pregabalin given preinduction blunted blood‑pressure spikes during laryngoscopy — evidence of reduced acute physiological stress response.

PubMed ID: 23464813

Pregabalin superior to transdermal fentanyl for neuropathic cancer pain with much higher responder rates — strong reduction in pain/tension symptoms.

PubMed ID: 25218827

Gabapentin reduced areas of experimental allodynia/hyperalgesia, consistent with lower nociceptive tension.

PubMed ID: 25448495

Perioperative gabapentin lowered plasma cortisol and catecholamines, direct physiologic evidence of reduced stress response.

PubMed ID: 24149930

Hot-flash and sleep improvements in menopausal women typically reduce stress.

PubMed ID: 25406046

Pregabalin reduced PTSD symptom severity (which includes anxiety/nervousness components) vs placebo.

PubMed ID: 25335172

Combination regimens including gabapentin produced larger short‑term pain improvements for arm/neck pain, lowering tension.

PubMed ID: 25317091

Low-dose gabapentin markedly reduced WASO and increased TST — corresponds to reduced nocturnal restlessness.

PubMed ID: 24521108

Pregabalin substantially improved RLS symptoms — direct, strong evidence for reduced restlessness.

PubMed ID: 24899755

Pregabalin reduced WASO and awakenings and increased slow-wave sleep in RLS — strong evidence for reduced restlessness.

PubMed ID: 25099523

Pruritus relief and improved sleep/QoL in dialysis patients likely reduce restlessness and nighttime movements.

PubMed ID: 25373811

Pregabalin substantially reduced headache days — likely reduces muscular/psychological tension associated with chronic headaches.

PubMed ID: 24819710

Large pain reductions in nursing home residents plausibly lowered tension.

PubMed ID: 25530068

Improved sleep and lower opioid needs with pregabalin in cancer patients could reduce restlessness.

PubMed ID: 24525635

Baclofen add‑on reduced PTSD hyperarousal and avoidance — clinically meaningful stress symptom reduction.

PubMed ID: 25176361

Perioperative gabapentin reduced post‑spinal headache severity and morphine use — less pain/tension in recovery period.

PubMed ID: 27343784

High‑dose gabapentin reduced etomidate‑induced myoclonus (muscle activity/tension) — direct reduction of involuntary muscle tension.

PubMed ID: 26034150

Pregabalin reduced anxiety in fibromyalgia patients, consistent with reduced nervousness.

PubMed ID: 26230741

Gabapentin produced small increases in early sedation and short‑term sleep benefit after knee replacement.

PubMed ID: 26200182

Perioperative gabapentin increased sedation—translates to increased calm/sedation.

PubMed ID: 26341878

Perioperative pregabalin reduced early and persistent neuropathic pain—may reduce muscle/nerve tension associated with pain.

PubMed ID: 25874578

Gabapentin enacarbil produced large, clinically meaningful reductions in RLS severity and related restlessness.

PubMed ID: 26123629

Gabapentin improved residual sleep problems in depressed patients similar to clonazepam; may increase calmness.

PubMed ID: 25597438

Pain relief and QoL gains with pregabalin combination likely reduce stress.

PubMed ID: 26749228

Preop gabapentin lowered HR/BP spikes and reduced preoperative anxiety in CABG patients (acute calming effect).

PubMed ID: 27018419

Low‑dose gabapentin produced no next‑day driving impairment, consistent with maintained steady energy without cognitive slowing.

PubMed ID: 26035523

Pregabalin improved sleep consolidation in fibromyalgia, reducing nocturnal restlessness/objective wake bouts.

PubMed ID: 28850523

Gabapentin improved sleep and pain in pediatric neuropathic pain—likely reducing restlessness.

PubMed ID: 26447687

Pregabalin improved cough symptoms and QoL; symptom relief can reduce stress related to chronic coughing.

PubMed ID: 26871201

Perioperative pregabalin reduced preoperative anxiety in neurosurgery patients.

PubMed ID: 27185699

Single preop pregabalin dose reduced early postop pain and opioid needs, which can reduce nervousness about pain.

PubMed ID: 27067343

Gabapentin enacarbil in RLS produced consistent improvements in IRLS scores and daily affairs/mood items (reduced restlessness).

PubMed ID: 27467714

Baclofen (GABA-B agonist) produced large reductions/complete resolution of muscle cramps — clear tension relief.

PubMed ID: 25756560

Pregabalin reduced pain and fibromyalgia-related tension/stiffness across pooled analyses.

PubMed ID: 27257288

Pregabalin reduced pain and improved function in fibromyalgia, which often lowers muscle/soft‑tissue tension.

PubMed ID: 27070434

Gabapentin reduced HADS anxiety scores in chronic pelvic pain (direct decrease in nervousness).

PubMed ID: 27500873

Pregabalin reduced craving/anxiety vs clonidine during opioid withdrawal (less nervousness).

PubMed ID: 29078970

Acupuncture + gabapentin improved restless legs symptoms and sleep more than gabapentin alone (direct effect on restlessness).

PubMed ID: 28805758

Noophen (GABA-derivative) reduced tension-type headache frequency/intensity in children—direct tension reduction.

PubMed ID: 28919128

Pregabalin reduced psychic anxiety items in schizophrenia (direct anxiolytic signal relevant to nervousness reduction).

PubMed ID: 30423587

Oral baclofen improved muscle tone and disability in spinal cord injury (direct GABA‑B agonist muscle‑relaxant effect relevant to reduced muscular tension).

PubMed ID: 30553555

Attenuation of hemodynamic and anxiety responses to intubation indicates reduced acute stress reactivity with pregabalin.

PubMed ID: 30359684

Prevention of chronic postmastectomy neuropathic pain likely reduces long‑term stress burden.

PubMed ID: 30354975

Intrathecal baclofen decreased spasm pain and spasticity — strong evidence for muscle/tone relaxation and reduced tension.

PubMed ID: 30115911

Reduced avoidance behaviour (anxiety model) indicates acute stress/anxiety‑reducing properties.

PubMed ID: 29925328

Oral gabapentin before paediatric strabismus surgery reduced emergence agitation and postoperative opioid need (clear calming effect).

PubMed ID: 29326296

Intrathecal baclofen significantly reduced poststroke spasticity (Ashworth scale) — direct reduction of muscular tension.

PubMed ID: 29420518

Single pre-op gabapentin dose reduced intra-/postoperative anxiety in eye surgery patients—direct clinical evidence of reduced nervousness.

PubMed ID: 30980177

Baclofen added to risperidone reduced hyperactivity/restlessness measures in children with ASD.

PubMed ID: 30783957

Topical baclofen after hemorrhoidectomy reduced pain and analgesic use—clinically meaningful reduction in post-op tension/discomfort.

PubMed ID: 30134301

Reduced postop pain and vomiting and lower anesthetic needs with pre-op gabapentin could lower perioperative stress.

PubMed ID: 31435774

Long-term pain relief with gabapentin should reduce stress related to chronic pain in many patients.

PubMed ID: 31648655

Pregabalin augmentation produced marked reductions in OCD symptoms and anxiety-related pathology—strong evidence for reduction in nervousness in this population.

PubMed ID: 31149930

Marked reduction in persistent post-surgical pain with perioperative pregabalin likely reduces long-term stress associated with chronic pain.

PubMed ID: 31638608

Pregabalin reduced preoperative anxiety in laparoscopic cholecystectomy patients.

PubMed ID: 31050023

Intrathecal baclofen improved individualized goals and reduced dystonia measures — strong evidence of muscle tone/tension reduction in severe dyskinetic CP.

PubMed ID: 31182874

Pregabalin reduced preoperative anxiety before gallbladder surgery.

PubMed ID: 31358085

Gabapentin significantly reduced preoperative anxiety (VAS) — direct evidence for reducing nervousness.

PubMed ID: 31596461

Measured postoperative state anxiety decreased with gabapentin—directly supports reduced nervousness.

PubMed ID: 31887853

Single-dose pregabalin before ACL surgery reduced early pain and prolonged time to analgesia request; clinically calming pre/postop effect.

PubMed ID: 31992495

Single 300 mg pregabalin reduced succinylcholine-induced fasciculations and post-op myalgia, lowering muscular tension/pain.

PubMed ID: 33064711

Well-powered RCT: 75 mg pregabalin produced ~2-point drop in preoperative anxiety VAS vs placebo (direct evidence).

PubMed ID: 34544324

Pregabalin plus exercise reduced myofascial pain and increased PPT and QoL — direct reduction in muscle/tension-related symptoms.

PubMed ID: 33172225

Pregabalin premedication reduced peri-procedural anxiety measured by VAS-A.

PubMed ID: 33563173

Gabapentin showed greater benefits for anxiety versus pregabalin in a small comparative trial.

PubMed ID: 34259401

Acupuncture increased GABA and lowered cortisol alongside improved sleep — physiological markers of reduced stress.

PubMed ID: 33797949

Alprazolam (GABAergic) acutely reduced subjective arousal in social-anxiety participants — strong evidence that GABAergic modulation produces calmness (drug, not oral GABA).

PubMed ID: 36243129

Pre-op gabapentin reduced intra-op pain and opioid use and increased satisfaction — reduces procedural stress.

PubMed ID: 35191232

Fewer and less frequent muscle cramps with pregabalin could reduce restlessness in affected patients.

PubMed ID: 37606659

Preprocedural gabapentin reduced early anxiety in Mohs surgery patients — direct clinical reduction in nervousness.

PubMed ID: 37039703

Gabapentin outperformed valerian for restless legs syndrome in dialysis patients — direct evidence of reduced restlessness in an RLS population.

PubMed ID: 37833019

Intrathecal baclofen markedly reduced spasticity (muscle tension) and improved function/QoL in spinal cord injury patients.

PubMed ID: 38063320

Gabapentin/baclofen both reduced nocturnal calf cramps and related discomfort — direct effect on muscle tension/cramps.

PubMed ID: 38321713

Improved HRV (parasympathetic predominance) and reduced depressive symptoms indicate reduced physiological/psychological stress.

PubMed ID: 38501980

Esketamine + pregabalin combination halved moderate-to-severe postoperative pain — clinically meaningful tension reduction (combination therapy).

PubMed ID: 39666082

Multimodal + gabapentin regimen with acupuncture produced substantial pain reductions and lower PHN — clear tension/pain relief.

PubMed ID: 38717697

Pregabalin + dexamethasone reduced anxiety scores in oral surgery patients — direct reduction in nervousness (short term).

PubMed ID: 38935013

Preop gabapentin sharply reduced postoperative pain and opioid use — strong evidence for lowering physical tension/pain.

PubMed ID: 39903013

Oral gabapentin premedication significantly reduced emergence agitation vs placebo in a large pediatric RCT — direct calming effect peri‑procedurally.

PubMed ID: 40673388

Pregabalin relieved neuropathic pain in diabetic neuropathy — reduced pain‑related muscle/psychological tension.

PubMed ID: 39969577

Adding pregabalin (with olanzapine) reduced nausea but increased sedation — sedation can be experienced as greater calmness (trade‑off).

PubMed ID: 39891093

Gabapentin premedication reduced emergence agitation, postoperative pain and opioid needs after rhinoplasty — clinically observable calming/reduced agitation.

PubMed ID: 39909068

Gabapentin enacarbil reduced nighttime agitation and increased total sleep time in dementia — direct reduction of restlessness.

PubMed ID: 40948158

Gabapentin+pregabalin reduced PHN pain and inflammatory markers — pain reduction often reduces bodily/psychic tension.

PubMed ID: 40663563

EstroG‑100 + 50 mg GABA produced early reductions in stress/anxiety in menopausal women (combo product).

PubMed ID: 41554764

GABA‑producing probiotic reduced anxiety (GAD‑7) and insomnia scores alongside urinary GABA increases.

PubMed ID: 41580462

Arbaclofen modulated limbic networks toward normalization in autism (supports reduced hyperarousal/greater calm).

PubMed ID: 37237331

Remimazolam (GABA_A agonist) produced stable induction and hemodynamic stability with sedative effects (strong sedation/calmness signal in clinical setting).

PubMed ID: 37789968

Low‑dose remimazolam provided hemodynamic stability with fewer adverse effects and sedative effect (supports calm/sedation).

PubMed ID: 38165145

Remimazolam achieved effective anesthesia with fewer hypotensive events and clear sedative profile (direct GABAergic sedation evidence).

PubMed ID: 2363531

Alfentanil potentiated the GABAergic sedative midazolam substantially (lowered ED50), showing how GABAergic activity produces sedation/hypnosis.

PubMed ID: 2141931

A GABA‑acting muscle relaxant reduced pain and improved function in acute low back pain → supports reduction in muscle tension.

PubMed ID: 10520979

Large RCT showed clonazepam markedly reduced panic attacks and anxiety — direct evidence for reduced nervousness via GABA‑A modulation.

PubMed ID: 10625720

Clomethiazole (GABA-A enhancer) increased sedation in stroke patients—demonstrates calm/sedative GABAergic effects.

PubMed ID: 11586699

Zolpidem reported as effective and well tolerated for insomnia in >1,000 patients — hypnotic effect implies increased calmness at bedtime for many patients.

PubMed ID: 11840583

Oral midazolam before anesthesia significantly lowered incidence/severity of emergence agitation (direct reduction in restlessness).

PubMed ID: 11943519

Epidural midazolam added to bupivacaine improved analgesia and sedation postoperatively — relevant to reducing muscular/tonic tension in postoperative pain.

PubMed ID: 12700707

Alprazolam markedly reduced panic responses in a controlled challenge — strong evidence for acute calming/anxiolysis.

PubMed ID: 12870055

Clonazepam significantly reduced panic attacks and anxiety vs placebo in a clinical trial.

PubMed ID: 15536461

Single-dose triazolam caused sedation and observer-rated sedation increases in older men — supports an acute calming/sedative effect.

PubMed ID: 15346702

IV midazolam premedication produced clinically meaningful anxiolysis and reduced postop nausea/vomiting; direct anxiolytic (calming) effect is well supported.

PubMed ID: 16190095

Repeated diazepam produced sedation and slowed responses, consistent with clinically meaningful calming/sedative effects from GABA(A) agonists.

PubMed ID: 17561543

Indiplon increased total sleep time and improved WASO/awakenings subjectively—reduces nighttime restlessness.

PubMed ID: 16647994

Intranasal midazolam (GABAergic) rapidly controlled seizures and is anxiolytic/sedative in clinical use; shows GABAergic calming action.

PubMed ID: 16676776

Tiagabine blunted afternoon–evening cortisol increases during sleep restriction—objective evidence of attenuated physiological stress response.

PubMed ID: 16533870

Diazepam prevented conditioned fear acquisition, a strong experimental demonstration of anxiolytic/calm effects.

PubMed ID: 17476705

Open‑label tiagabine showed social anxiety symptom improvement, indicating reduced social nervousness.

PubMed ID: 17653697

Gaboxadol reduced night awakenings and increased SWS—objective reduction in nocturnal restlessness.

PubMed ID: 18441707

Alprazolam (GABAergic) lowered autonomic arousal and tachycardia episodes—translates to calmer state.

PubMed ID: 19346160

Gaboxadol reduced awakenings and increased TST — decreases nocturnal restlessness and likely daytime restlessness via better sleep.

PubMed ID: 19945340

EVT‑201 markedly reduced WASO and latency — likely reduces restlessness by improving consolidated sleep.

PubMed ID: 20041911

Ocinaplon produced large anxiolytic effects — directly reduces nervousness via GABA(A) modulation.

PubMed ID: 19194157

Midazolam produced clear sedative/cognitive suppression effects consistent with increased calm/sedation.

PubMed ID: 22626945

Clonazepam reduced tinnitus-related annoyance and handicap, accompanied by decreased subjective distress.

PubMed ID: 23635869

Kava RCT reduced anxiety (HAM‑A) indicating stress reduction clinically.

PubMed ID: 23348009

Pregnenolone increased allopregnanolone and reduced amygdala/insula activation — mechanistic evidence for reduced stress reactivity.

PubMed ID: 28319848

Sepranolone reduced PMDD negative mood and impairment — consistent with reduced stress in that syndrome.

PubMed ID: 29268740

Lorazepam reduced subjective anxiety in a stress-provoking task—strong evidence relevant to reducing nervousness.

PubMed ID: 28418172

Clobazam (GABA-A modulator) reduced pain ratings in chronic low-back pain, consistent with decreased muscle/tension-related pain.

PubMed ID: 30177236

Phase‑3 brexanolone results replicate rapid symptomatic calming/reduction in depressive symptoms.

PubMed ID: 29793605

ABP-700 (GABAergic hypnotic) produced clear sedative/hypnotic effects in volunteers, consistent with short-term calmness.

PubMed ID: 31483961

SAGE-217's antidepressant and sedative profile suggests increased baseline calm/less agitation for some patients.

PubMed ID: 31618495

Taurine significantly reduced tic severity in youths, directly supporting reduced motor restlessness in that population.

PubMed ID: 34190962

Zuranolone produced meaningful anxiolytic improvements (HAM‑A) in PPD — direct clinical evidence for reduced nervousness.

PubMed ID: 33798307

Acupuncture improved sleep and reduced hyperarousal with increased serum GABA in chronic insomnia — clinical signal of reduced arousal/calmness.

PubMed ID: 35897310

SNK12 reduced TMD (POMS), lowered salivary cortisol and LF/HF ratio after stress — direct evidence of reduced physiological and subjective stress.

PubMed ID: 36334013

Remimazolam (GABA‑A agonist) produced reliable clinical sedation in large RCT → strong evidence for induced calm/sedation (drug).

PubMed ID: 36506792

Remimazolam caused effective procedural sedation with favorable safety vs propofol — clinically calming effect.

PubMed ID: 35348021

Diazepam produced autonomic/haemodynamic changes consistent with sedation/relaxation despite some BP variability — supports acute calm/sedation.

PubMed ID: 37242260

Nightly oral GABA associated with improved subjective sleep/sleepiness measures vs baseline — supports increased calm/relaxation (subjective).

PubMed ID: 39180365

Vitamin B6 (100 mg/d) reduced sensory over‑responsivity and postural disorder scores—consistent with reduced muscular/ sensory tension via enhanced GABA synthesis.

PubMed ID: 38869657

B. breve increased fecal GABA and suppressed HPA‑axis hormones—direct evidence for reduced physiologic stress markers.

PubMed ID: 38325605

Zuranolone produced broad improvements in wellbeing and functioning consistent with increased calm via GABA‑A potentiation.

PubMed ID: 39401812

Autism rehabilitation ± acupuncture improved behavioral measures and Glu/GABA ratio, consistent with less restlessness.

PubMed ID: 39302437

Zuranolone caused marked next‑day sedation and sleepiness in healthy adults—strong evidence of pronounced calming/sedating effect (adverse for daytime function).

PubMed ID: 39798036

L. plantarum + L. brevis probiotic reduced hyperactivity/impulsivity and commission errors—direct evidence of reduced restlessness/impulsivity in children.

PubMed ID: 40205333

Ciprofol provided superior, sustained sedation in ventilated patients (GABA‑A agonist)—strong clinical calming/sedative effect in ICU context.

PubMed ID: 40530830

Ciprofol caused less injection pain and gentler hemodynamics vs propofol—peri‑procedural reductions in acute nervousness/anxiety.

PubMed ID: 39805976

Ciprofol (GABA‑A agonist) is a potent sedative/anesthetic with pronounced calming/suppressive effects in procedural settings.

PubMed ID: 40312029

Significant reductions in anxiety (GAD‑7) with GABA‑producing probiotic map closely to reduced perceived stress.

PubMed ID: 27939574

Perioperative pregabalin improved global QoR‑40 (multidimensional recovery/wellbeing).

PubMed ID: 26814307

Gabapentin enacarbil gave consistent pain reduction in PHN, which supports improved daily wellbeing.

PubMed ID: 27759644

Adding gabapentin to oxycodone reduced opioid use and improved quality of life over months (direct wellbeing improvement).

PubMed ID: 25756560

Pregabalin reduced pain and improved multiple symptoms in fibromyalgia across pooled trials.

PubMed ID: 27467714

Baclofen produced large, clinically meaningful resolution of muscle cramps in cirrhosis, markedly improving QoL.

PubMed ID: 27067343

RLS trials of gabapentin enacarbil showed meaningful QOL and mood improvements vs placebo.

PubMed ID: 27037091

Extended‑release gabapentin led to clinically meaningful pain and sleep improvements that predicted global benefit.

PubMed ID: 26670614

Pregabalin reduced neuropathic pain in prediabetic patients; symptomatic relief supports wellbeing.

PubMed ID: 27916242

Pregabalin+methylcobalamin improved chronic post‑thoracotomy pain and related outcomes vs diclofenac.

PubMed ID: 27475753

Adolescent fibromyalgia trial showed secondary PGIC improvements indicating better overall wellbeing.

PubMed ID: 26447687

Pregabalin added to speech therapy improved cough‑related quality of life significantly.

PubMed ID: 15064265

Large RCT: preoperative gabapentin reduced pain and opioid use, which typically improves wellbeing.

PubMed ID: 14624703

Baclofen improved retention and depressive symptoms, implying better overall wellbeing.

PubMed ID: 12217947

Baclofen increased abstinence and reduced craving/anxiety — likely improves wellbeing in dependent patients.

PubMed ID: 8261880

Baclofen improved anxiety/depression clinically, which commonly raises overall wellbeing.

PubMed ID: 31793540

Pantogam improved psychomotor development in preterm infants, a meaningful functional/ wellbeing outcome.

PubMed ID: 21350425

Pantogam add-on improved anxiety, memory and QOLIE-31 scores — directly supports improved wellbeing.

PubMed ID: 38325605

Integrated zuranolone data showed broad, durable improvements in SF‑36 domains—strong evidence for improved overall wellbeing via GABA‑A PAM.

PubMed ID: 37491938

Zuranolone produced clinically meaningful improvement in postpartum depression, which would reflect improved overall wellbeing in that population.

PubMed ID: 35088753

taVNS and citalopram produced similar reductions in depression scores and earlier remission with taVNS — clinical improvement tied to peripheral GABA changes.

PubMed ID: 34190962

Zuranolone produced marked reductions in depression/anxiety scores and higher response/remission rates — supports improved overall wellbeing from GABA‑A PAM therapy.

PubMed ID: 31483961

SAGE-217 produced large reductions in depression scores over 14 days, which is likely to improve overall wellbeing for patients.

PubMed ID: 29716670

Baclofen increased percentage days abstinent and delayed relapse in an RCT — meaningful clinical benefit likely to improve overall wellbeing.

PubMed ID: 32150232

Gabapentin increased abstinence and no-heavy-drinking rates—clinically meaningful outcomes that typically improve overall wellbeing.

PubMed ID: 31833590

Baclofen increased low-risk drinking success and reduced consumption at 12 months—likely to improve wellbeing though safety concerns reduce confidence.

PubMed ID: 34120336

High‑dose gabapentin pilot reduced heavy drinking and increased abstinence days—positive clinical signal for wellbeing.

PubMed ID: 38828963

Gabapentin improved insomnia and (in subgroups) drinking outcomes — likely to improve overall wellbeing where effective.

PubMed ID: 40760644

TEAS improved sleep, anxiety and depression markedly and increased serum GABA — strong overall wellbeing signal.

PubMed ID: 39317299

12‑month multi‑ingredient supplement improved some cognitive tests and modestly increased serum GABA — positive wellbeing signal.

PubMed ID: 10629347

Sublingual glycine raised CSF GABA and was associated with better early stroke outcomes and lower short‑term mortality trends — meaningful clinical benefit.

PubMed ID: 8421205

Long‑term intrathecal baclofen produced substantial reduction in spasticity and spasms, likely improving patients’ daily functioning and wellbeing.

PubMed ID: 8771597

Pooled trials: more patients on gabapentin reported improved general well‑being vs placebo (46% vs 29%) — moderate clinical signal in epilepsy populations.

PubMed ID: 9450159

Pivagabine improved global clinical status and reduced fatigue in neurasthenia.

PubMed ID: 9450158

Open pivagabine trial reported large improvements in mood/anxiety (uncontrolled).

PubMed ID: 29278929

Preoperative gabapentin greatly reduced catheter pain and analgesic use — clear patient‑centered benefit (wellbeing) in surgical setting.

PubMed ID: 9846778

Gabapentin improved pain, sleep interference and QoL in postherpetic neuralgia (large RCT).

PubMed ID: 9846777

Gabapentin improved pain, sleep and QoL in diabetic neuropathy (large RCT).

PubMed ID: 9851651

Gabapentin associated with slower strength loss and longer survival in ALS (comparative results).

PubMed ID: 10210035

Vigabatrin produced substantial seizure reductions vs valproate—seizure control commonly improves overall wellbeing.

PubMed ID: 10958046

Small migraine trial with gabapentin reduced headache frequency/intensity in ~half of patients—some wellbeing benefit for responders.

PubMed ID: 10695888

Long-term intrathecal baclofen produced sustained functional and QoL improvements despite procedural events.

PubMed ID: 11051124

Add-on gabapentin or vigabatrin produced meaningful seizure reductions and some QoL measures—moderate benefit to wellbeing.

PubMed ID: 11251695

Randomized gabapentin migraine trial produced clinically meaningful reductions in migraine frequency and responder rates—likely to improve overall wellbeing in responders.

PubMed ID: 11407953

Gabapentin in learning-disabled patients improved seizure control and carer-rated general health and sleep, indicating broader wellbeing gains.

PubMed ID: 11690735

PHN trial showed improved sleep and global patient ratings with gabapentin, indicating improved wellbeing.

PubMed ID: 11305405

Large pediatric refractory epilepsy series showed substantial seizure reductions—likely to improve wellbeing for many children/caregivers.

PubMed ID: 12406532

Large neuropathic pain RCT: modest pain reduction and improvements in several QoL domains.

PubMed ID: 12707429

Pregabalin reduced pain and improved sleep in PHN, increasing responder rates and QoL.

PubMed ID: 14694042

Gabapentin increased headache-free days and improved pain-related QOL in chronic daily headache.

PubMed ID: 12811359

Dose‑response seizure reductions for pregabalin imply downstream wellbeing benefits (indirect).

PubMed ID: 15596757

Pregabalin produced pain relief and sleep improvement in diabetic neuropathy, supporting better wellbeing.

PubMed ID: 15082123

Pregabalin improved pain, sleep and mental QoL in PHN — clear overall-wellbeing signal.

PubMed ID: 15820913

Pain reduction and sleep improvement in neuropathic pain likely raise overall wellbeing.

PubMed ID: 15621380

Perioperative gabapentin reduced pain/opioid use and improved pulmonary function—net wellbeing benefit.

PubMed ID: 15911152

Chronic neuropathic pain relief with sleep benefits supports improved wellbeing.

PubMed ID: 16416358

Long‑term sustained pain reductions with gabapentin correlate with improved wellbeing.

PubMed ID: 15818684

Fibromyalgia responders showed less pain, better sleep and reduced fatigue—overall wellbeing improved.

PubMed ID: 15774213

Seizure reduction and cognitive gains with gabapentin support improved quality of life.

PubMed ID: 16227648

Vigabatrin produced higher rates of large seizure reductions and EEG improvements—likely better wellbeing.

PubMed ID: 15845693

Reduced opioid use, lower anxiety and better early function after ACL repair indicate wellbeing gains.

PubMed ID: 15976235

Gabapentin lowered pain and opioid needs in ICU patients with Guillain–Barré—likely improves wellbeing.

PubMed ID: 16361302

Adding gabapentin to epidural analgesia reduced pain and improved satisfaction.

PubMed ID: 15951655

Open study reported reductions in chronic pain and improved sleep—both contribute to better overall wellbeing.

PubMed ID: 16244006

Gabapentin-containing multimodal therapy reduced acute analgesic needs and substantially lowered 3‑month chronic pain incidence.

PubMed ID: 16961166

Pain and sleep improvements in PHN translated into higher patient‑centred benefit.

PubMed ID: 16368826

Gabapentin around hysterectomy reduced pain and cut PCA morphine use (~24%), improving recovery and wellbeing.

PubMed ID: 16205904

Pregabalin produced rapid, clinically meaningful neuropathic pain reductions — likely to improve wellbeing.

PubMed ID: 17393438

Gabapentin improved pain, sleep and global measures in fibromyalgia (directly improves wellbeing).

PubMed ID: 17207299

Postop gabapentin with wound infusion reduced morphine use and late pain — likely improved recovery wellbeing.

PubMed ID: 17679749

Marked reduction in uremic pruritus would substantially improve patient comfort and wellbeing.

PubMed ID: 17631400

Pregabalin improved pain, sleep interference and global impressions — strong QoL signal.

PubMed ID: 17604592

Gabapentin added to opioids produced earlier and greater neuropathic pain relief and fewer side effects — likely wellbeing gain.

PubMed ID: 17450066

Gabapentin improved walking distance, pain and sensory recovery in lumbar stenosis — meaningful functional benefit.

PubMed ID: 18524684

Pregabalin improved pain, sleep and global measures (PGIC) in fibromyalgia—reflecting improved overall wellbeing.

PubMed ID: 18278830

Pregabalin produced significant pain relief and global improvement in fibromyalgia trials.

PubMed ID: 17917611

Gabapentin halved hot‑flash scores and improved vasomotor QoL — clinically meaningful improvement in wellbeing via a GABA analogue.

PubMed ID: 18796160

Pregabalin markedly reduced neuropathic pain and increased responder rates, which supports improved patient wellbeing.

PubMed ID: 18978320

Statistically significant anxiety and depressive symptom improvements in elderly GAD likely improve overall wellbeing.

PubMed ID: 19910619

Perioperative pregabalin prevented chronic neuropathic pain and reduced opioid use with better early ROM—clear functional benefits.

PubMed ID: 19667976

Large RLS trial showed clinically meaningful symptom and CGI improvements, likely improving overall wellbeing.

PubMed ID: 19222545

Adjunctive pregabalin reduced seizure frequency in refractory epilepsy — meaningful functional/wellbeing impact.

PubMed ID: 19900234

Pregabalin provided comparable pain relief with fewer side effects vs amitriptyline in diabetic neuropathy, supportive of wellbeing.

PubMed ID: 19534799

Large pregabalin fibromyalgia programs showed sleep and pain improvements translating into global wellbeing gains.

PubMed ID: 20006256

Intrathecal baclofen reduced immediate opioid need and chronic pain incidence — clinically important wellbeing gains.

PubMed ID: 19727980

Single‑dose pregabalin halved 24‑h morphine use and improved pain/nausea — meaningful perioperative wellbeing effect.

PubMed ID: 19410509

Pregabalin improved sleep quality and disturbance beyond pain in fibromyalgia — important for overall wellbeing.

PubMed ID: 19921480

Pregabalin+celecoxib produced large pain reductions in chronic low back pain — likely large wellbeing benefits.

PubMed ID: 19238802

Gabapentin prodrug reduced RLS severity and improved sleep architecture — substantial symptomatic wellbeing benefit.

PubMed ID: 19798503

Large primary‑care cohort showed major reductions in pain, sleep improvement and mood gains with pregabalin—broad wellbeing signal.

PubMed ID: 20722471

Yoga increased brain GABA with correlated mood/anxiety improvement — likely to boost overall wellbeing.

PubMed ID: 20347225

Meta-analysis: moderate-to-large pain reductions link to broad improvements across health domains and QALY gains.

PubMed ID: 21185118

Pregabalin EERW study showed substantial pain reduction in responders — clinically meaningful wellbeing signal.

PubMed ID: 21965636

Pregabalin (450 mg/day) improved Patient Global Impression and function in fibromyalgia RCTs.

PubMed ID: 21397402

Sodium oxybate increased pain responder rates and improved fatigue/sleep—clinically meaningful global benefits in fibromyalgia.

PubMed ID: 21683078

Pregabalin produced greater pain relief and higher global improvement rates in chronic pancreatitis patients—translates to improved wellbeing.

PubMed ID: 22159931

Perioperative gabapentin/pregabalin reduced opioid needs and increased patient satisfaction after lumbar surgery (improved satisfaction/wellbeing).

PubMed ID: 21368587

Substantial reduction in social anxiety with pregabalin likely improves overall wellbeing for affected patients (indirect to dietary GABA).

PubMed ID: 21627766

Gabapentin enacarbil improved pain, sleep, mood and patient‑reported outcomes in PHN patients.

PubMed ID: 21465325

Adding gabapentin to antiemetics increased complete control of CINV (overall and delayed), improving patient wellbeing during chemo.

PubMed ID: 21242741

Long-term gabapentin enacarbil improved RLS symptoms and CGI-I responders were high — improved global wellbeing.

PubMed ID: 22951084

Gabapentin improved cough-specific quality-of-life (LCQ) — direct improvement in disease-specific wellbeing.

PubMed ID: 22991449

Pain and sleep improvements with pregabalin in diabetic neuropathy likely increased overall wellbeing.

PubMed ID: 23053645

Anxiety reductions in breast cancer survivors likely translate to improved wellbeing.

PubMed ID: 23149085

Gabapentin gastroretentive produced clinically meaningful pain relief in PHN—likely to improve overall wellbeing.

PubMed ID: 22459341

Preoperative pregabalin reduced postoperative pain and opioid use after cholecystectomy—likely improved early postoperative wellbeing.

PubMed ID: 22373942

Gabapentin reduced cannabis use/withdrawal and improved executive function—multidimensional improvement consistent with better overall wellbeing.

PubMed ID: 22644743

Both gabapentin and pregabalin improved pain, mood (BDI) and sleep (PSQI) in hemodialysis neuropathy—broad improvements in wellbeing domains.

PubMed ID: 22387644

Gabapentin lowered succinylcholine myalgia incidence and reduced opioid consumption—benefits that support postoperative wellbeing.

PubMed ID: 23223108

Intrathecal baclofen reduced several pain qualities in CRPS with dystonia—clinically relevant improvement in patient wellbeing (open‑label evidence).

PubMed ID: 22045156

Perioperative pregabalin lowered early pain and markedly reduced morphine use after spinal surgery—meaningful recovery/wellbeing benefit.

PubMed ID: 22909343

Gabapentin and pregabalin reduced uraemic pruritus and neuropathic pain in dialysis patients, improving symptom burden and wellbeing (randomized crossover).

PubMed ID: 23732189

Combination duloxetine+pregabalin produced meaningful pain relief in diabetic neuropathy — improved symptom control that contributes to overall wellbeing (clinical trial).

PubMed ID: 23816671

Perioperative pregabalin reduced early pain and opioid use after CABG, benefits likely to improve short‑term wellbeing/recovery.

PubMed ID: 23602345

Gabapentin enacarbil produced clinically meaningful neuropathic pain reductions, which commonly translate into improved wellbeing.

PubMed ID: 24171880

Large reductions in hot flashes and their intensity/duration often lead to meaningful quality‑of‑life and wellbeing gains.

PubMed ID: 22801243

Large RCT showed meaningful pain reduction and better patient global impression with gastroretentive gabapentin (PHN) — direct improvement in overall wellbeing.

PubMed ID: 23572323

Crossover trial in haemodialysis patients: gabapentin/pregabalin substantially reduced neuropathic pain and improved HR‑QoL — strong signal for improved wellbeing.

PubMed ID: 23865122

Gabapentin markedly reduced migraine frequency/severity/duration — large symptom improvements that strongly affect overall wellbeing.

PubMed ID: 23345639

Pregabalin improved pain and sleep interference in SCI patients — clinically meaningful improvements that support wellbeing.

PubMed ID: 23998397

Pooled pregabalin trials for spinal cord injury neuropathic pain showed consistent pain and global improvement (PGIC) benefits.

PubMed ID: 23464813

Pregabalin produced large, clinically meaningful pain relief and higher satisfaction vs fentanyl in neuropathic cancer pain — strong improved‑wellbeing signal.

PubMed ID: 24571062

Perioperative gabapentin markedly lowered 24‑hr morphine needs, implying better postoperative comfort and wellbeing.

PubMed ID: 24320856

Pregabalin reduced 48‑hr morphine consumption after hip arthroplasty and likely improved comfort/wellbeing.

PubMed ID: 24149930

Gabapentin reduced hot flashes and sleep interference in menopausal women — clear QoL/wellbeing improvement.

PubMed ID: 24518937

Preop gabapentin reduced post‑cesarean pain and morphine use — supports improved early wellbeing.

PubMed ID: 23983064

Pregabalin reduced pain in fibromyalgia — meaningful wellbeing impact.

PubMed ID: 25317091

Robust objective sleep improvements likely translate to improved daytime wellbeing.

PubMed ID: 24521108

Pregabalin produced clinically meaningful RLS symptom and global improvement rates.

PubMed ID: 24899755

Objective and subjective sleep improvements in RLS strongly enhance wellbeing.

PubMed ID: 25099523

Pregabalin significantly reduced pruritus and improved sleep and HRQoL in dialysis patients.

PubMed ID: 24980426

Perioperative gabapentin reduced opioid need and improved early ROM — positive short-term wellbeing impact.

PubMed ID: 24819710

Stepped pain-treatment protocol produced large pain and functional improvements — strong wellbeing gains.

PubMed ID: 24384657

Preop pregabalin improved pain and functional outcomes post‑discectomy — notable wellbeing benefits.

PubMed ID: 25530068

Pregabalin reduced opioid needs and improved sleep in cancer patients, supporting better overall wellbeing.

PubMed ID: 26115203

PHN trials showed pain and sleep improvements that predicted better patient global impression (PGIC).

PubMed ID: 26409117

Integrated analyses linked pain/sleep improvement with overall improvement on PGIC.

PubMed ID: 25874578

RLS trial reported improvements in mood, pain and function—broad QoL benefits.

PubMed ID: 25597438

Adding pregabalin improved pain relief and quality of life in herpetic neuralgia patients.

PubMed ID: 26718698

300 mg pregabalin reduced opioid need and early pain, which can improve patient wellbeing after cesarean.

PubMed ID: 27043168

Large benefit in uremic pruritus responder rate likely improved overall wellbeing in dialysis patients.

PubMed ID: 26945817

Pregabalin plus antioxidants reduced pain recurrence after pancreatic duct clearance, improving patient outcomes.

PubMed ID: 26048580

High‑dose baclofen substantially increased abstinence in one RCT—successful abstinence often improves overall wellbeing.

PubMed ID: 24190578

Gabapentin improved drinking outcomes, craving, sleep and mood—overall clinical benefit consistent with improved wellbeing.

PubMed ID: 22302014

Pregabalin augmentation produced clinically meaningful anxiolysis, likely improving overall wellbeing in GAD patients.

PubMed ID: 21454917

Gabapentin + naltrexone improved early drinking outcomes and sleep — contributes to short‑term wellbeing in dependent patients.

PubMed ID: 18541827

Topiramate improved psychosocial well‑being and multiple metabolic/health measures in alcohol‑dependent patients.

PubMed ID: 18068515

Baclofen substantially increased abstinence and improved clinical outcomes in alcohol‑dependent cirrhotics, likely improving overall wellbeing.

PubMed ID: 18095197

Single 1200 mg preop gabapentin markedly reduced pain and opioid need and improved satisfaction after surgery.

PubMed ID: 18052562

Gabapentin decreased drinking/craving and increased abstinent days after detox, outcomes associated with meaningful improvements in wellbeing.

PubMed ID: 30177236

Brexanolone produced clinically meaningful HAM‑D reductions and symptomatic improvement in postpartum depression, implying improved overall wellbeing.

PubMed ID: 28319848

Sepranolone reduced PMDD symptom burden and impairment in adherent subgroup — supports improved wellbeing in that population.

PubMed ID: 23348009

Neurosteroid increases with pregnenolone and reduced limbic activation imply improvements in affective regulation and wellbeing.

PubMed ID: 23635869

Kava's anxiolytic effects and increased remission rate suggest broader wellbeing improvements in anxious individuals.

PubMed ID: 22002961

Nightly sleep architecture and maintenance gains (gaboxadol) support potential downstream wellbeing benefits.

PubMed ID: 19945340

Substantial objective sleep gains in elderly (EVT‑201) plausibly translate to improved overall wellbeing.

PubMed ID: 18853933

Sustained sleep improvements with gaboxadol could plausibly enhance wellbeing (indirect inference from objective sleep gains).

PubMed ID: 14616189

Tiagabine significantly increased cocaine-free urines in dependent patients, an outcome likely linked to improved overall wellbeing when sustained.

PubMed ID: 14578014

Flumazenil reduced benzodiazepine withdrawal symptoms, craving and short-term relapse, improving clinical outcomes and wellbeing in dependent patients.

PubMed ID: 11586699

Zolpidem trial reported 89.4% overall improvement rate for insomnia patients; improved sleep often translates into better overall wellbeing for many subjects.

PubMed ID: 40948158

Adding pregabalin to gabapentin improved pain and lowered inflammatory cytokines in PHN — clinically meaningful improvement in health status/QoL.

PubMed ID: 40673388

Pregabalin produced clinically meaningful neuropathic pain relief vs placebo — alleviating chronic pain can improve overall wellbeing.

PubMed ID: 40107652

Large metabolomics study found higher plasma GABA in a multi‑metabolite signature associated with lower long‑term mortality — observational link to better long‑term health.

PubMed ID: 39158916

GABA‑analogue reduced pain and sleep interference in neuropathy, translating to better patient‑reported outcomes.

PubMed ID: 38321713

RCT showed improved HRV, sleep efficiency and depressive symptoms with oral GABA — clear multidomain wellbeing gains.

PubMed ID: 38041897

Combined vigabatrin+steroid treatment gave faster spasm control in infants — clinical benefit likely improves family/patient wellbeing.

PubMed ID: 37833019

Intrathecal baclofen reduced spasticity and improved quality of life in spinal cord injury patients — strong clinical QoL signal (GABA‑B agonist).

PubMed ID: 36104745

Pregabalin+agomelatine improved mental‑health measures and QoL relative to pregabalin alone.

PubMed ID: 36168693

Picamilon + ginkgo improved cognitive scores and EQ‑5D quality‑of‑life vs ginkgo alone in chronic brain ischemia — direct improvement in QoL with a GABA‑containing drug (co‑treatment confound).

PubMed ID: 35220330

Pregabalin produced robust neuropathic pain reductions in a large trial, an outcome linked to better wellbeing.

PubMed ID: 35665521

Baclofen reduced reflux events and improved symptomatic wellbeing in patients with positive symptom–reflux association.

PubMed ID: 35615728

Pregabalin reduced pain and increased sleep duration in PHN, outcomes that tend to improve overall wellbeing.

PubMed ID: 35557479

Pregabalin improved itch‑related quality of life vs ketotifen in hemodialysis patients.

PubMed ID: 36259684

Reinforces clinically meaningful pain and QOL benefits across pregabalin-containing regimens.

PubMed ID: 36007534

Large diabetic-neuropathy pathways including pregabalin produced clinically meaningful pain reduction and QOL gains.

PubMed ID: 34781972

Perioperative gabapentin reduced opioid use and smoothed pain, increasing patient comfort and perceived wellbeing post-op.

PubMed ID: 34854403

Combining methylcobalamin with pregabalin/duloxetine produced meaningful pain and sensory improvements and better QoL — supports wellbeing from GABAergic drugs.

PubMed ID: 34924405

rTMS-induced GABA changes correlated with sustained motor functional improvement, which translates into improved overall wellbeing in stroke patients.

PubMed ID: 33340245

Gabapentin produced pain relief comparable to duloxetine in diabetic neuropathy—clinical symptom improvement that supports wellbeing.

PubMed ID: 32886447

Pregabalin reduced pain and disease impact (FIQ) in fibromyalgia, consistent with improved wellbeing.

PubMed ID: 32770612

Prophylactic gabapentin during chemoradiation reduced mucositis pain and systemic symptoms, improving short-term patient-reported status.

PubMed ID: 33451591

Gabapentin markedly reduced nausea/vomiting and increased oral intake and satisfaction in hyperemesis gravidarum—strong direct improvement in wellbeing.

PubMed ID: 31925721

Pregabalin substantially outperformed duloxetine for taxane neuropathy (high responder rates) — meaningful symptomatic and quality‑of‑life impact.

PubMed ID: 33180985

Preventive vigabatrin delayed seizures and reduced drug‑resistant epilepsy — major long‑term wellbeing benefit in infants with tuberous sclerosis.

PubMed ID: 31358085

Preoperative gabapentin greatly lowered 24h opioid use and anxiety — likely to improve immediate postoperative wellbeing.

PubMed ID: 30730476

Preop pregabalin + magnesium reduced 24h morphine by ~32% and early pain — clinically relevant improvement in postoperative recovery/wellbeing.

PubMed ID: 30773731

Gabapentin markedly reduced taxane‑induced neuropathy and NCV decline — strong objective benefit likely improving overall wellbeing.

PubMed ID: 31062253

Gabapentin reduced pain and improved function in knee osteoarthritis vs acetaminophen over 3 months—functional benefits supportive of wellbeing.

PubMed ID: 31149930

Perioperative pregabalin (± ketamine) greatly reduced persistent post-cardiac-surgery pain at 3–6 months — large impact on long-term wellbeing.

PubMed ID: 30663077

Pregabalin significantly reduced abdominal pain and some IBS symptoms over 12 weeks—likely improving patient wellbeing.

PubMed ID: 31435774

Gabapentin produced clinically meaningful reductions in chronic pelvic pain over 24 weeks with high responder rates, supporting improved wellbeing.

PubMed ID: 31869451

Pilot trial found methadone + low-dose gabapentin reduced opioid needs and improved some QoL domains vs high-dose gabapentin arm—suggests QoL gain when used judiciously.

PubMed ID: 30980177

Baclofen improved multiple behavioral subscales in ASD, reflecting clinically meaningful wellbeing gains.

PubMed ID: 30008787

Randomized double‑blind trial of GABA‑enriched fermented seaweed showed biomarker, cognitive and physical improvements in older adults.

PubMed ID: 29976533

Gabapentin reduced uremic pruritus and improved Dermatology QoL, a direct improvement in wellbeing for dialysis patients.

PubMed ID: 30354975

Intrathecal baclofen (GABA‑B agonist) improved EQ‑5D utility versus oral therapy — meaningful QoL gain.

PubMed ID: 30359684

Perioperative pregabalin markedly reduced incidence of postmastectomy neuropathic pain and lowered VAS scores, improving longer‑term wellbeing.

PubMed ID: 28488610

Pregabalin improved anxiety/depression (HAD) alongside pain relief in central poststroke pain—meaningful overall wellbeing effect.

PubMed ID: 27753650

Pregabalin CR provided sustained pain control in PHN, reducing loss‑of‑response events (improves chronic wellbeing).

PubMed ID: 25529830

Pooled pregabalin trials in fibromyalgia reported rapid improvements in sleep quality NRS within 1–2 days.

PubMed ID: 25317090

Single‑dose gabapentin produced large, dose‑dependent increases in TST and slow‑wave sleep and reduced WASO by PSG.

PubMed ID: 25317091

Randomized study: gabapentin increased total sleep time and reduced WASO significantly.

PubMed ID: 24521108

Pregabalin improved RLS symptoms and objective/subjective sleep measures.

PubMed ID: 24899755

Pregabalin reduced WASO, reduced awakenings and increased slow-wave sleep in RLS patients.

PubMed ID: 25099523

Pregabalin reduced pruritus and improved sleep quality in dialysis patients.

PubMed ID: 25530068

Pregabalin added to morphine improved sleep quality in cancer patients with neuropathic pain (randomized crossover).

PubMed ID: 25876342

Warm acupuncture + auricular therapy raised GABA/Glu and improved clinical sleep vs estazolam in insomnia trial — indirect but relevant to GABA modulation and sleep.

PubMed ID: 26714731

Well‑powered RCT: pregabalin reduced pain and sleep interference in PHN patients (significant improvement in sleep scores).

PubMed ID: 26230741

Perioperative gabapentin improved sleep during the first two nights post‑op.

PubMed ID: 26115203

Gastroretentive gabapentin improved sleep interference in PHN trials (validated measures).

PubMed ID: 25874578

Gabapentin enacarbil substantially reduced RLS‑related sleep disturbance and improved sleep measures.

PubMed ID: 26123629

Randomized trial: gabapentin improved PSQI/ISI comparably to clonazepam in depressed patients.

PubMed ID: 25272094

Large pooled analyses: pregabalin produced rapid and sustained improvement in pain-related sleep interference across thousands of patients.

PubMed ID: 26160608

Gabapentin reduced menopausal night-sweat severity and night sweats, which can improve sleep quality.

PubMed ID: 27043168

Gabapentin reduced severe pruritus after dialysis, likely improving sleep by reducing itching at night.

PubMed ID: 26035523

Objective polysomnography showed increased sleep bout duration and fewer wake bouts with pregabalin.

PubMed ID: 28850523

In children with neuropathic pain, gabapentin improved pain and sleep vs baseline, similar to amitriptyline.

PubMed ID: 26982602

Combination pregabalin + duloxetine improved pain and sleep measures in fibromyalgia.

PubMed ID: 27475753

Adolescent fibromyalgia trial reported improvements in some sleep endpoints as secondary outcomes.

PubMed ID: 27397522

Pregabalin markedly reduced pruritus and improved skin‑related QoL, likely benefiting sleep.

PubMed ID: 26871201

Perioperative pregabalin improved subjective sleep quality in neurosurgery patients.

PubMed ID: 27037091

Gastroretentive gabapentin reduced pain and pain-related sleep problems in PHN, with strong patient-level correlations.

PubMed ID: 26885528

Gabapentin+B vitamins increased sleep hours in painful diabetic neuropathy patients.

PubMed ID: 25968451

Pregabalin improved sleep interference in DPN patients (direct evidence of sleep benefit).

PubMed ID: 29078970

Acupuncture added to gabapentin improved PSQI (sleep quality) in restless legs disease.

PubMed ID: 28150436

Gabapentin decreased nocturia and nocturia-related symptoms—direct mechanism to reduce nighttime awakenings.

PubMed ID: 28371941

Mirogabalin reduced sleep interference in diabetic neuropathy (large RCT) — clear GABAergic‑class signal for sleep improvements (indirect to supplement).

PubMed ID: 30454846

Melatonin added to gabapentin users produced clear, early improvements in PSQI sleep quality and reduced daytime sleepiness.

PubMed ID: 30123399

Single‑dose gabapentinoids improved first‑night sleep scores after surgery.

PubMed ID: 31354243

Pregabalin reduced sleep interference in painful diabetic neuropathy vs baseline/controls (improved sleep domain).

PubMed ID: 32936427

Trazodone added to gabapentin improved sleep measures as secondary outcomes in painful diabetic neuropathy study.

PubMed ID: 32886447

Pregabalin improved pain and sleep (Leeds Sleep index) in fibromyalgia RCT — supports improved sleep quality via GABAergic drug.

PubMed ID: 33563173

Gabapentin arm showed improved insomnia/fatigue in low back pain trial — clinical evidence of GABAergic drugs helping sleep.

PubMed ID: 34259401

Acupuncture increased serum GABA and produced PSQI improvements comparable to estazolam — solid association between GABA increase and better sleep (non-supplement intervention).

PubMed ID: 36007534

Neuropathic pain program including pregabalin reported ISI improvements — indirect evidence for better sleep with GABAergic agents.

PubMed ID: 36327047

Auricular bloodletting + acupressure raised GABA and melatonin and improved PSQI in insomnia — direct sleep benefit associated with increased GABA.

PubMed ID: 35615728

Pregabalin substantially increased continuous sleep duration vs carbamazepine in PHN patients.

PubMed ID: 35585718

Large comparative trial found pregabalin had relatively favorable probability for sleep disturbance outcomes vs comparators.

PubMed ID: 35442367

Pregabalin arm showed improvements in some sleep quality metrics in knee OA RCT (drug that modulates GABAergic pathways).

PubMed ID: 36273066

Adding CoQ10 to pregabalin improved sleep interference more than pregabalin alone in diabetic neuropathy trial.

PubMed ID: 35325767

rTMS increased left DLPFC GABA and significantly improved insomnia severity index in randomized trial — direct link between increased brain GABA and insomnia improvement (intervention not oral GABA).

PubMed ID: 37068811

Acupuncture + rTMS improved PSQI and altered serum GABA in depressed/insomnia patients (multi‑modal but shows sleep benefit linked to GABA changes).

PubMed ID: 38063320

Gabapentin and baclofen reduced nocturnal calf cramps and improved insomnia scores in RCT — clear improvement in sleep‑related symptoms.

PubMed ID: 38321713

200 mg/day oral GABA increased sleep efficiency and improved sleep measures in a randomized trial — strong direct evidence.

PubMed ID: 39158916

Large RCT of a GABA‑analogue reduced pain and sleep interference in diabetic neuropathy — robust evidence for improved sleep interference.

PubMed ID: 39381868

Short-course pregabalin reduced immediate postoperative sleep disturbance and improved sleep scores — clinical sleep benefit in perioperative setting.

PubMed ID: 39164806

Topical gabapentin reduced dialysis-related itching that disrupts sleep — indirect but clinically relevant sleep improvement.

PubMed ID: 38803031

Gabapentin in ICU markedly increased slow‑wave sleep and total sleep time with large physiologic effect — strong direct evidence for improved objective sleep quality.

PubMed ID: 38778572

Gabapentin strongly reduced post‑burn itch and improved sleep in that population — clear clinically meaningful sleep benefit.

PubMed ID: 39521326

Perioperative gabapentin improved early postoperative sleep quality in a randomized double‑blind trial (drug evidence).

PubMed ID: 40418104

Pregabalin combined with antidepressants improved sleep quality (PSQI) in postherpetic neuralgia patients compared with baseline — clinical sleep benefit.

PubMed ID: 40615016

Pregabalin was used as a comparator in fibromyalgia where sleep improvements were measured; pregabalin had some sleep effects but the trial primarily tested exercise.

PubMed ID: 39909068

Gabapentin enacarbil increased total sleep time and reduced nighttime wake in dementia patients — clear sleep‑quality improvement.

PubMed ID: 41554764

Randomized trial of a GABA‑producing probiotic improved ISI and produced small objective sleep increases and urinary GABA rise.

PubMed ID: 1363657

Zolpidem (GABA‑A acting hypnotic) robustly shortens sleep onset, reduces awakenings, and increases total sleep time → strong evidence for GABA‑A modulation improving sleep.

PubMed ID: 11586699

Large clinical trial of zolpidem reported high effectiveness for insomnia, including improved sleep initiation and overall sleep outcomes.

PubMed ID: 11471907

Zolpidem improved self-rated sleep quality and reduced subjective jet lag in travelers (direct evidence of improved sleep quality).

PubMed ID: 12128237

Adding low-dose clonazepam to fluoxetine reduced insomnia symptoms and accelerated early sleep-related improvement.

PubMed ID: 16260179

Tiagabine (GABA reuptake inhibitor) increased slow-wave sleep and reduced wake after sleep onset in primary insomnia — dose-dependent, physiologically meaningful improvements in sleep quality.

PubMed ID: 16553019

Tiagabine increased slow‑wave (deep) sleep in elderly insomniacs and reduced awakenings at some doses — objective improvement in sleep architecture though subjective sleep ratings did not improve.

PubMed ID: 17557435

Tiagabine increased Stage 3+4 sleep dose‑dependently in primary insomnia (objective SWS increase) but did not change total sleep time or most subjective measures.

PubMed ID: 17561543

Indiplon (GABA(A)α1-preferring potentiator) increased subjective total sleep time ~36–49 min and improved multiple sleep measures in elderly insomniacs.

PubMed ID: 16676776

Tiagabine enhanced slow‑wave sleep and protected attention during sleep restriction, supporting improved sleep architecture and restorative quality.

PubMed ID: 17765013

Gaboxadol (extrasynaptic GABA(A) agonist) significantly reduced WASO and improved sleep maintenance in a large RCT—strong objective sleep-quality evidence.

PubMed ID: 17653697

Gaboxadol improved sleep maintenance, increased slow‑wave sleep and reduced night awakenings in primary insomnia (PSG-confirmed).

PubMed ID: 17552374

Gaboxadol increased total sleep time and slow-wave activity and decreased WASO in a phase‑advance transient insomnia model (robust objective and subjective effects).

PubMed ID: 18853933

Large 30‑night RCT: gaboxadol (GABA‑A agonist) improved WASO and increased SWS — strong direct sleep‑quality evidence.

PubMed ID: 19487320

Gaboxadol altered sleep EEG by increasing slow‑wave power (deep sleep) — mechanistic support for improved sleep quality.

PubMed ID: 19346160

Large RCT: gaboxadol increased total sleep time and reduced awakenings — direct, strong evidence for improved sleep quality via extrasynaptic GABA‑A agonism.

PubMed ID: 19945340

EVT‑201 (GABA‑A modulator) significantly increased TST and reduced WASO/latency in elderly — robust sleep quality improvement.

PubMed ID: 20191935

Gaboxadol (GABAergic) increased total sleep time and shortened sleep onset in large RCTs (modest but consistent effects).

PubMed ID: 19345644

EVT201 (GABA-A PAM) increased total sleep time and reduced awakenings with PSG-confirmed improvements — strong direct evidence.

PubMed ID: 39777869

Acupuncture+moxibustion increased serum GABA and produced clinically improved PSQI sleep scores in a small trial.

PubMed ID: 39302437

Zuranolone produced sedation/increased sleepiness and impaired next‑day driving—evidence of strong sleep‑promoting/sedating effects (but with next‑day impairment).

PubMed ID: 39119911

Zolpidem‑ER improved early and middle insomnia in depressed outpatients — clinically meaningful sleep benefit.

PubMed ID: 38869657

B. breve probiotic increased fecal GABA and improved PSQI (subjective sleep quality) in stressed/insomniac adults.

PubMed ID: 39683592

Melissa officinalis phytosome reduced ISI and increased slow‑wave (deep) sleep—direct objective and subjective sleep quality benefit.

PubMed ID: 38201970

Yeast mannan increased fecal GABA and objectively lengthened N3 deep sleep in adults with mild constipation.

PubMed ID: 37242260

Nightly oral GABA produced within‑subject improvements in overall subjective sleep (OSA total) though placebo effects noted.

PubMed ID: 36194395

Dexmedetomidine (non‑GABA drug) markedly increased total sleep time/efficiency in ventilated ICU patients — strong sleep benefit (drug context).

PubMed ID: 33798307

Acupuncture trial in chronic insomnia showed improved PSQI and pre‑sleep arousal alongside increased serum GABA — direct sleep-quality improvement with GABA association.

PubMed ID: 33443117

Gaboxadol (extrasynaptic GABA(A) agonist) improved global clinical measures and reduced actigraphic sleep‑onset latency (~25.7 min) in Angelman syndrome — strong sleep‑quality signal (esp. sleep initiation).

PubMed ID: 31712421

Brotizolam (GABA-A agonist) is a hypnotic that affects sleep architecture (but impairs post-awakening performance), supporting sleep-promoting action.

PubMed ID: 29793605

ABP-700 produced dose-dependent hypnotic/sedative effects, supporting ability to improve sleep initiation/depth in controlled settings.

PubMed ID: 26872077

Phase III: eszopiclone increased total sleep time and sleep efficiency by PSG — strong objective evidence for improved sleep quality (GABA‑A hypnotic).

PubMed ID: 22003345

Gaboxadol (GABA-A agonist) produced robust dose-related increases in NREM low-frequency power—clear pharmacodynamic evidence of deeper NREM sleep.

PubMed ID: 22002961

Randomized study under noise model: gaboxadol increased SWS, TST and reduced WASO and latency — consistent support.

PubMed ID: 21102998

Gaboxadol and zolpidem differentially improved sleep microstructure with links to subjective sleep quality (phase‑advance model).

PubMed ID: 34373044

Safinamide improved nocturnal sleep scores and RBD symptoms in PD patients (multi‑mechanism drug with GABAergic actions).

PubMed ID: 18517036

Gaboxadol (GABA‑A SWS enhancer) increased slow‑wave sleep and lowered daytime sleepiness during restriction.

PubMed ID: 18855801

One‑week gabapentin reduced cue‑elicited arousal and improved PSQI sleep scores in alcohol‑dependent volunteers.

PubMed ID: 21454917

Large RCT: adding gabapentin to naltrexone improved sleep quality during the dosing period.

PubMed ID: 24190578

Gabapentin RCT showed dose‑related improvements in sleep measures in alcohol‑dependent patients (strong direct evidence).

PubMed ID: 24983280

Pregabalin reduced sleep interference in neuropathic pain, consistent with meaningful sleep benefit.

PubMed ID: 38828963

Gabapentin RCT in AUD substantially improved insomnia severity (especially in those with baseline insomnia).

PubMed ID: 40760644

TEAS RCT produced very large, rapid improvements in multiple sleep measures (PSQI/ISI) and raised serum GABA.

PubMed ID: 37678556

Pregabalin reduced neuropathic pain and improved secondary sleep scale—direct evidence that a GABAergic analogue can improve sleep quality in pain patients.

PubMed ID: 40169760

GABA‑producing probiotic modestly but significantly improved PSQI sleep scores at 8 weeks.

PubMed ID: 39970858

Standardized lime peel supplement (GABA_A‑activating properties) improved objective PSG measures (sleep latency, WASO, efficiency) and daytime sleepiness.

PubMed ID: 9450157

Pivagabine treatment improved sleep and awakening quality in insomnia linked to mood disorders.

PubMed ID: 9450160

Randomized pediatric study: pivagabine improved sleep disturbances.

PubMed ID: 9846778

Gabapentin significantly improved sleep interference in postherpetic neuralgia (large RCT).

PubMed ID: 9846777

Gabapentin improved sleep and QoL in painful diabetic neuropathy (large RCT).

PubMed ID: 10695888

Long-term intrathecal baclofen reduced spasticity and reported sustained QoL benefits including sleep in cerebral palsy patients.

PubMed ID: 11407953

Gabapentin add-on in learning-disabled group produced carer-rated sleep improvements.

PubMed ID: 11690735

Large RCT in postherpetic neuralgia: gabapentin significantly improved sleep interference vs placebo.

PubMed ID: 12707429

Pregabalin improved sleep in postherpetic neuralgia RCT; strong sleep-related outcome.

PubMed ID: 15596757

Pregabalin RCT in diabetic neuropathy showed early and sustained improvement in sleep.

PubMed ID: 15082123

Pregabalin reduced sleep interference and improved mental QoL in PHN; supports sleep quality gains.

PubMed ID: 15288403

Pregabalin reduced sleep interference in painful diabetic neuropathy, indicating improved sleep quality.

PubMed ID: 15820913

Pregabalin 600 mg/day improved sleep interference in painful diabetic neuropathy (robust trial).

PubMed ID: 15911152

Pregabalin reduced pain-related sleep interference in chronic neuropathic pain.

PubMed ID: 15818684

Pregabalin improved sleep quality and fatigue in fibromyalgia (large RCT).

PubMed ID: 15951655

Open 3-month study reported improved sleep with gabapentin (tiagabine showed even greater sleep benefit).

PubMed ID: 16961166

Gabapentin improved sleep quality substantially in post‑herpetic neuralgia patients.

PubMed ID: 16466610

Large pregabalin trial showed dose-dependent pain reduction and significant improvements in sleep-interference scores.

PubMed ID: 17130411

Pregabalin improved sleep interference in central neuropathic pain patients (significant effect).

PubMed ID: 17146104

Gabapentin substantially reduced hot flashes, a known disruptor of sleep, supporting improved sleep quality.

PubMed ID: 17393438

Gabapentin significantly improved MOS Sleep Problems Index and global measures in fibromyalgia.

PubMed ID: 17631400

Pregabalin 600 mg/day significantly improved pain-related sleep interference in diabetic neuropathy RCT.

PubMed ID: 18524684

Large RCT: pregabalin produced statistically and clinically meaningful sleep improvements in fibromyalgia patients.

PubMed ID: 18258368

Gabapentin reduced pain-related sleep interference in traumatic peripheral nerve injury (secondary outcome).

PubMed ID: 19333167

Gabapentin ER reduced pain‑related sleep interference in PHN, improving sleep scores.

PubMed ID: 19415540

Gabapentin RCT substantially reduced hot flashes and improved PSQI sleep quality in breast cancer survivors.

PubMed ID: 19188575

Gabapentin‑enacarbil produced meaningful RLS benefit and improved associated sleep outcomes (IRLS-related improvements).

PubMed ID: 19667976

Gabapentin enacarbil (RLS) produced large improvements in RLS severity, which commonly yields improved sleep quality.

PubMed ID: 19534799

Large randomized pregabalin data demonstrated clinically meaningful sleep quality improvements.

PubMed ID: 19410509

Large pregabalin trials in fibromyalgia showed robust, dose‑dependent improvements in multiple sleep measures.

PubMed ID: 19238802

Gabapentin prodrug markedly improved RLS symptoms and objective sleep stages in randomized crossover trial.

PubMed ID: 20427750

Randomized trial: pregabalin improved RLS symptoms, reduced limb movements and increased slow‑wave sleep (objective sleep benefit).

PubMed ID: 20511481

Gabapentin enacarbil maintenance reduced RLS relapse (clinical improvement) and is associated with better sleep continuity.

PubMed ID: 20818838

Gabapentin ER showed secondary analyses suggesting modest sleep improvement in postherpetic neuralgia.

PubMed ID: 20347225

Meta-analysis: greater pain relief associated with improvements in sleep domains.

PubMed ID: 20236172

Pregabalin trial showed significant improvements in sleep-related measures in neuropathic pain patients.

PubMed ID: 20466589

Pregabalin reduced RLS symptoms dose-dependently with associated sleep benefits at higher doses.

PubMed ID: 20639738

Pregabalin combined with TENS improved sleep interference in PHN patients versus sham TENS.

PubMed ID: 21166852

Pregabalin (300–600 mg/day) reduced pain and improved sleep interference in diabetic peripheral neuropathy — moderate evidence for sleep quality improvement (indirect).

PubMed ID: 21397402

Sodium oxybate produced clear improvements in sleep disturbance and fatigue in fibromyalgia trials.

PubMed ID: 21527006

Post Sleep Questionnaire reliably detected sleep and daytime function improvements across 12 weeks in RLS trials—evidence of consistent change detection.

PubMed ID: 21444113

Flexible‑dose pregabalin improved sleep interference in neuropathic pain patients (validated clinical outcome).

PubMed ID: 21627766

Gabapentin enacarbil reduced PHN pain and improved sleep and mood vs placebo (reported sleep improvement).

PubMed ID: 21611981

Gabapentin enacarbil significantly reduced wake time during sleep and PLMs with arousal in RLS—strong objective sleep benefit.

PubMed ID: 21316855

Pregabalin improved MOS‑sleep in a large trial (secondary outcome), indicating better sleep quality.

PubMed ID: 21242741

Gabapentin enacarbil for RLS produced sustained symptom improvements that typically improve sleep quality.

PubMed ID: 23062189

Pregabalin improved sleep quality scores in fibromyalgia trial.

PubMed ID: 22991449

Pregabalin improved objective sleep continuity and total sleep time in diabetic neuropathy.

PubMed ID: 22497967

Gastroretentive gabapentin reduced sleep interference in painful diabetic neuropathy vs placebo—randomized evidence of sleep benefit.

PubMed ID: 23121149

Gabapentin enacarbil reduced RLS severity; RLS treatment typically reduces nocturnal awakenings.

PubMed ID: 23089176

Pregabalin markedly reduced post‑burn itch (a cause of sleep disruption), likely improving sleep for affected patients.

PubMed ID: 22644743

Gabapentin/pregabalin improved PSQI sleep scores in hemodialysis patients—clinical sleep benefit reported.

PubMed ID: 22232085

Pregabalin produced a robust, objective improvement in sleep continuity (WASO −19.2 min) in fibromyalgia—strong RCT evidence for improved sleep quality.

PubMed ID: 24171880

Gabapentin 900 mg/day markedly reduced hot‑flash frequency/intensity in postmenopausal women; because hot flashes disturb sleep, this supports improved sleep quality.

PubMed ID: 22801243

Gastroretentive gabapentin in PHN significantly reduced 'sleep interference' scores, indicating improved sleep quality in that patient population.

PubMed ID: 23345639

Pregabalin trial in spinal cord injury reported significant improvement in sleep‑related pain interference — direct clinical evidence of sleep benefit.

PubMed ID: 23998397

Pooled pregabalin trials showed reduced pain and improved responder rates; pain reduction often translates to better sleep (moderate indirect evidence).

PubMed ID: 25430812

Pregabalin after thoracotomy significantly lowered sleep interference versus NSAID, indicating improved sleep.

PubMed ID: 24149930

Large RCT: gastroretentive gabapentin improved sleep interference and hot-flash-related sleep.

PubMed ID: 27343784

Gabapentin prevented etomidate‑induced myoclonus (reduced involuntary muscle activity) in humans.

PubMed ID: 21350425

Pantogam improved anxiety and memory, consistent with reduced mental agitation and improved relaxation.

PubMed ID: 8261880

Baclofen produced clinically meaningful reductions in anxiety/depression (mental relaxation).

PubMed ID: 11123486

Baclofen improved the mental component of opiate withdrawal (mental relaxation evidence).

PubMed ID: 16841627

Pregabalin's rapid anxiolytic effects imply increased mental relaxation.

PubMed ID: 18855801

Gabapentin reduced arousal and improved sleep metrics — consistent with greater relaxation before bedtime.

PubMed ID: 21456104

Pregabalin's anxiolytic effect in GAD reflects improved mental relaxation and lowered psychic anxiety.

PubMed ID: 21454917

Gabapentin addition improved sleep and insomnia measures during dosing period — supports pre‑bed relaxation.

PubMed ID: 22302014

Pregabalin significantly reduced anxiety symptoms and responder rates—consistent with improved mental relaxation.

PubMed ID: 24190578

Gabapentin improved sleep measures and subjective sleep quality in alcohol‑dependent outpatients—supports pre‑bed relaxation.

PubMed ID: 24983280

Pregabalin reduced sleep interference and improved sleep‑related outcomes, consistent with better pre‑bed relaxation.

PubMed ID: 26659543

GHB induced dose-related sedation and dizziness—acute bedtime relaxation effect plausible.

PubMed ID: 34256607

Gabapentin-induced shifts in cortical GABA/glutamate relate to later abstinence—mechanistic support for mental-relaxation effects.

PubMed ID: 38828963

Gabapentin’s sleep/anxiolytic effects contribute to subjective mental relaxation.

PubMed ID: 40760644

TEAS greatly improved sleep indices and anxiety — consistent with pre‑bed relaxation effects.

PubMed ID: 37678556

Pregabalin improved sleep-related secondary outcomes in neuropathic pain, implying pre‑bedtime relaxation benefits for some users.

PubMed ID: 39970858

Lime peel supplement (GABA_A‑linked) improved sleep latency and reduced wake time on PSG, consistent with pre‑bed relaxation effects.

PubMed ID: 1998451

Oral baclofen improved quadriceps spasticity in MS patients, consistent with muscle relaxation.

PubMed ID: 8421205

Chronic intrathecal baclofen produced large, sustained reductions in rigidity (Ashworth score) and muscle spasm scores.

PubMed ID: 8751632

Implanted intrathecal baclofen produced large, clinically meaningful reductions in rigidity and spasm—very strong evidence for muscle relaxation.

PubMed ID: 9450158

Open pivagabine trial reported improvements in depression/anxiety (mental relaxation implied).

PubMed ID: 9450157

Pivagabine improved sleep metrics including awakening/sleep quality in insomnia contexts.

PubMed ID: 9846778

Gabapentin improved sleep and mood in PHN, supporting mental relaxation.

PubMed ID: 10440462

Symptomatic improvement in social phobia consistent with increased mental relaxation in social contexts.

PubMed ID: 10565592

Vigabatrin produced marked reductions in infantile spasms (reduction of involuntary muscle activity).

PubMed ID: 9924905

Vigabatrin produced dose-related seizure reductions — reduces involuntary motor events that resemble muscle overactivity.

PubMed ID: 10666558

Midazolam produced marked sedative/amnesic effects — strong pharmacologic evidence of mental relaxation with GABAergic modulation (drug context).

PubMed ID: 10695888

Continuous intrathecal baclofen produced large, sustained decreases in spasticity (Ashworth score) over ~3 years—strong evidence for muscle relaxation.

PubMed ID: 12197845

Single-dose baclofen reduced reflux metrics via GABA-B effects on LES relaxations — relevant to smooth muscle tone modulation.

PubMed ID: 12631652

Acute and 1-month baclofen reduced reflux episodes and improved symptoms — consistent GABA-B muscular/tonic activity.

PubMed ID: 12707429

Pregabalin improved sleep interference in PHN; relevant to pre-sleep relaxation.

PubMed ID: 12611835

Pregabalin reduced HAM‑A scores, indicating cognitive/psychic relaxation.

PubMed ID: 15082123

Pregabalin reduced sleep problems and improved mental QoL; supports bedtime relaxation.

PubMed ID: 16143734

Pregabalin decreased overall and psychic anxiety in GAD, supporting mental relaxation.

PubMed ID: 15710092

Randomized pilot showed gabapentin improved Ashworth spasticity scores.

PubMed ID: 15845693

Lowered preop anxiety and improved comfort suggest mental relaxation.

PubMed ID: 15738746

Pregabalin reduced psychic anxiety subscale on HAM‑A — indicates mental/cognitive relaxation.

PubMed ID: 16466610

Pregabalin improved sleep-interference in PHN, consistent with facilitating pre-sleep relaxation.

PubMed ID: 17030096

Gabapentin produced large reductions in jaw-muscle pain and hyperalgesia consistent with muscle relaxation/less hypertonicity.

PubMed ID: 18524684

Pregabalin's sleep benefits in fibromyalgia patients would support pre-bed relaxation for many users.

PubMed ID: 18978320

Anxiolytic and modest antidepressant effects of pregabalin in GAD imply improved mental relaxation.

PubMed ID: 19458926

Baclofen (GABA‑B agonist) and eperisone objectively improved spasticity, ROM and electrophysiology—strong muscle‑relaxant evidence.

PubMed ID: 19534799

Pregabalin trials reported improved sleep quality and diary measures implying better pre‑sleep relaxation.

PubMed ID: 20006256

Intrathecal baclofen (GABA-B agonist) produces muscle tone reduction; study showed perioperative analgesic and longer-term pain benefits.

PubMed ID: 19410509

Pregabalin improved sleep initiation and sleep disturbance measures, consistent with pre‑bed relaxation benefits.

PubMed ID: 19587470

Sustained‑release and gastric‑retentive baclofen significantly improved muscle tone and spasm scores.

PubMed ID: 20722471

Increases in brain GABA with yoga correlated with reduced anxiety and improved subjective relaxation.

PubMed ID: 21388079

Preoperative gabapentin reduced anxiety and increased satisfaction, consistent with enhanced mental relaxation in the acute setting.

PubMed ID: 21397402

Sodium oxybate improved sleep disturbance—likely promotes relaxation around bedtime.

PubMed ID: 21368587

Large pregabalin trial produced marked reductions in social anxiety — consistent with improved mental relaxation in social contexts (indirect).

PubMed ID: 21611981

Objective sleep consolidation with gabapentin enacarbil (less wake time/PLMs) supports pre‑bed relaxation and better sleep onset.

PubMed ID: 22203366

Direct study: oral GABA attenuated stress-related EEG changes and improved mood under mental load.

PubMed ID: 23053645

Anxiolytic effects in breast cancer survivors imply improved mental relaxation.

PubMed ID: 22232085

Pregabalin improved sleep continuity and reduced WASO—patients may experience greater relaxation at bedtime and throughout the night.

PubMed ID: 23223108

Intrathecal baclofen (a GABA‑B agonist) treated dystonia/CRPS—direct effect on muscle tone/relaxation.

PubMed ID: 22770920

Gabapentin reduced self‑reported state anxiety preoperatively, consistent with enhanced mental relaxation in an acute setting.

PubMed ID: 23377862

Marked reductions in preoperative anxiety and worry indicate improved mental relaxation after a single 1,200 mg gabapentin dose.

PubMed ID: 23620421

Gabapentin premedication reduced anxiety and improved recovery in cataract patients — supports increased mental relaxation.

PubMed ID: 23582109

Baclofen significantly reduced spasticity (modified Ashworth scale) in MS patients — direct and strong evidence for muscle relaxation via GABA-B agonist.

PubMed ID: 25448495

Physiologic reductions in cortisol/catecholamines and reduced pain support improved mental relaxation perioperatively.

PubMed ID: 24149930

Reduced hot flashes and sleep interference likely help relaxation before bed.

PubMed ID: 25317090

Single‑dose gabapentin improved sleep continuity and increased slow‑wave sleep without next‑day impairment — supports pre‑bedtime relaxation effect.

PubMed ID: 25052238

Baclofen produced marked cessation of hiccups — consistent with GABA-B mediated muscle-relaxant effect.

PubMed ID: 25317091

Large improvements in objective sleep measures support notable mental relaxation.

PubMed ID: 24521108

RLS control reduces limb movements and arousal before bed, promoting relaxation.

PubMed ID: 24899755

Pregabalin reduced WASO/awakenings and increased slow-wave sleep improving daytime mental relaxation.

PubMed ID: 25099523

Pruritus relief and improved sleep/QoL produce clear mental relaxation in dialysis patients.

PubMed ID: 25530068

Improved sleep quality with pregabalin suggests better pre‑bed relaxation in patients with neuropathic pain.

PubMed ID: 26115203

G‑GR improved pain‑related interference and sleep—supporting mental relaxation.

PubMed ID: 26341878

Pregabalin reduced early post‑thoracotomy pain and long‑term neuropathic pain—may reduce muscle guarding/spasm.

PubMed ID: 25874578

RLS symptom control reduces nocturnal restlessness and aids relaxation at night.

PubMed ID: 26123629

Gabapentin improved insomnia metrics similar to clonazepam, implying easier pre‑bed relaxation.

PubMed ID: 25272094

Pregabalin reduced sleep interference quickly, which could help patients feel more relaxed approaching bedtime.

PubMed ID: 26749228

Reduced preoperative anxiety and physiologic arousal with gabapentin suggests mental relaxation in that acute context.

PubMed ID: 26035523

Objective increase in sleep bout duration and fewer awakenings with pregabalin suggests better pre‑sleep relaxation/sleep consolidation.

PubMed ID: 26871201

Perioperative pregabalin improved preop anxiety and sleep, consistent with mental relaxation.

PubMed ID: 27037091

Extended‑release gabapentin reduced pain-related sleep problems, likely aiding pre-bedtime relaxation.

PubMed ID: 27467714

Baclofen 30 mg/day produced marked reduction/resolution of muscle cramps in cirrhosis — strong muscle-relaxant effect.

PubMed ID: 25968451

Pregabalin improved sleep interference in DPN, which can help with pre‑bed relaxation.

PubMed ID: 27939574

Pregabalin improved emotional state and comfort postoperatively — subjective mental relaxation effect.

PubMed ID: 28086137

Comparative trial in spasticity: baclofen and tolperisone both improved muscle tone and functional outcomes (direct muscle-relaxant evidence).

PubMed ID: 30423587

Oral baclofen (GABA‑B agonist) produced clinically meaningful reductions in spasticity and improved functional scores — strong direct evidence for muscle relaxation from a GABAergic agent (highly relevant pharmacology).

PubMed ID: 30354975

Intrathecal baclofen produced clear reductions in spasm‑related pain and improved function — strong muscle‑relaxant evidence.

PubMed ID: 30454846

Melatonin added to gabapentin users led to quicker improvements in sleep quality and less daytime sleepiness — supports pre‑bed relaxation.

PubMed ID: 29925328

Reduced emergence agitation and lower opioid need indicate improved perioperative mental calm with gabapentin premedication.

PubMed ID: 29326296

Intrathecal baclofen produced a clear and clinically meaningful reduction in spasticity (muscle relaxation).

PubMed ID: 31648655

Large reductions in OCD severity with pregabalin augmentation are consistent with substantial mental relaxation for affected patients.

PubMed ID: 31638608

Reduced preoperative anxiety reflects mental relaxation after pregabalin.

PubMed ID: 31050023

Intrathecal baclofen (GABA-B agonist) produced clinically meaningful dystonia/tone reduction — direct muscle‑relaxant evidence.

PubMed ID: 31358085

Marked decrease in preop anxiety implies mental relaxation with single‑dose gabapentin.

PubMed ID: 31596461

Reduction in postoperative anxiety suggests increased mental relaxation in the immediate postoperative period.

PubMed ID: 32936427

Trazodone on top of gabapentin improved sleep measures—agents like trazodone/gabapentin are often used to promote pre‑sleep relaxation.

PubMed ID: 31887853

Pre-op pregabalin reduced early pain after ACL surgery and delayed analgesic request; supports reduced muscle-related postoperative discomfort.

PubMed ID: 31992495

Randomized trial: single 300 mg pregabalin reduced succinylcholine-induced fasciculations and postoperative myalgia (direct muscle-relaxation effect).

PubMed ID: 33064711

Single-dose pregabalin produced rapid anxiolysis preoperatively — analogous to promoting pre-bed relaxation in some contexts.

PubMed ID: 34259401

Intervention raised serum GABA, lowered cortisol and improved sleep quality — supports pre-bed relaxation.

PubMed ID: 33797949

Subjective arousal reduction after alprazolam points to mental relaxation via GABAergic modulation.

PubMed ID: 36327047

Auricular interventions increased melatonin and GABA and improved PSQI — consistent with pre-bed relaxation facilitation.

PubMed ID: 35191232

Pregabalin significantly reduced weekly muscle cramp frequency in cirrhosis — strong signal for muscle relaxation.

PubMed ID: 35325767

rTMS increased DLPFC GABA and ISI improved — supports pre‑sleep relaxation via increased cortical GABA in insomnia patients (intervention not oral GABA).

PubMed ID: 37833019

Intrathecal baclofen produced large, durable reductions in spasticity — direct and strong muscle relaxation evidence (GABA‑B agonist).

PubMed ID: 38063320

Oral gabapentin/baclofen both reduced nocturnal cramps and leg pain — clinically meaningful muscle symptom relief.

PubMed ID: 38321713

Improvements in autonomic regulation and depressive symptoms with oral GABA are consistent with enhanced mental relaxation.

PubMed ID: 39163908

Probiotic lowering rumination/cognitive reactivity supports subjective mental relaxation.

PubMed ID: 38191158

Acupuncture + rehab improved spasm and increased serum GABA — direct clinical signal of muscle tone reduction (though intervention multimodal).

PubMed ID: 39903013

Gabapentin premedication reduced emergence agitation and increased sedation — subjective and objective signs of mental calming.

PubMed ID: 39891093

Similar perioperative calming and reduced agitation with gabapentin supports mental relaxation.

PubMed ID: 39909068

Gabapentin enacarbil reduced nighttime agitation and increased sleep time — conducive to more relaxed pre‑bedtime state.

PubMed ID: 41554764

GABA‑producing probiotic improved insomnia severity and anxiety—all consistent with better pre‑bed relaxation.

PubMed ID: 41580462

Arbaclofen normalized limbic PAC abnormalities—supports neural basis for reduced mental hyperarousal (mechanistic evidence).

PubMed ID: 37237331

Remimazolam’s sedative/GABAergic effects produce profound acute mental relaxation in procedural context.

PubMed ID: 2141931

GABA‑acting muscle relaxant reduced pain and improved function in low back pain → direct support for muscle relaxation effects of GABAergic drugs.

PubMed ID: 1363657

Zolpidem and other GABA‑A modulators produce sedative effects that help relaxation prior to sleep.

PubMed ID: 10520979

Clonazepam’s clinical anxiolytic effects translate to subjective mental relaxation in panic disorder patients.

PubMed ID: 11586699

Zolpidem significantly improved difficulty falling asleep and overall insomnia symptoms in a large sample — strong evidence it promotes pre-bedtime relaxation and sleep initiation.

PubMed ID: 11471907

Zolpidem improved sleep quality in travelers and is commonly used for pre-bedtime sleep induction/relaxation.

PubMed ID: 11840583

Midazolam reduced emergence agitation and emotional distress perioperatively (contextual mental relaxation).

PubMed ID: 12128237

Low-dose clonazepam added to fluoxetine reduced insomnia and improved early sleep—consistent with pre-bedtime relaxation.

PubMed ID: 12700707

Alprazolam attenuated subjective panic and HPA response to a stressor (supports mental relaxation).

PubMed ID: 14658975

Tiagabine improved anxiety and sleep in GAD, consistent with subjective mental relaxation.

PubMed ID: 15536461

Triazolam produced acute sedation — consistent with facilitating relaxation before bed (short-term hypnotic).

PubMed ID: 15346702

Midazolam premedication caused anxiolysis and reduced distress in perioperative context — supports mental relaxation in acute setting.

PubMed ID: 16190095

Repeated diazepam produced sedation and slowed saccades and is known to exert clinically meaningful muscle‑relaxant effects — physiologic GABAergic muscle relaxation evidence.

PubMed ID: 17557435

Tiagabine increased deep sleep (SWS), which could facilitate better pre‑bed relaxation though subjective effects were limited.

PubMed ID: 17561543

Indiplon improved subjective sleep onset and sleep quality, consistent with enhanced pre‑bedtime relaxation and sleep initiation.

PubMed ID: 16533870

Diazepam blocked fear conditioning, indicating lowered mental arousal to threat—mental relaxation evidence.

PubMed ID: 17765013

Gaboxadol improved sleep maintenance and had some effects on sleep onset measures—supports pre‑bedtime relaxation.

PubMed ID: 17694911

Midazolam reduced interference and enhanced retention of pre‑learned material (retrograde facilitation) — may reflect reduced mental chatter/interference.

PubMed ID: 19346160

Gaboxadol improved sleep onset and depth — supports pre‑bed relaxation via GABAergic action.

PubMed ID: 19945340

EVT‑201 reduced sleep latency and increased TST — consistent with improved pre‑bed relaxation.

PubMed ID: 19345644

EVT201 reduced sleep latency and increased TST — supports pre‑bedtime relaxation and readiness for sleep.

PubMed ID: 20041911

Ocinaplon's anxiolytic action implies improved mental relaxation via GABA(A) modulation.

PubMed ID: 23635869

Kava reduced anxiety and increased remission — supports subjective mental relaxation in anxious subjects.

PubMed ID: 23348009

Pregnenolone increased allopregnanolone and decreased limbic reactivity, consistent with improved mental calm/regulation.

PubMed ID: 26872077

Eszopiclone improved sleep efficiency and TST — commonly used to promote pre‑bedtime relaxation and sleep onset.

PubMed ID: 29268740

Lorazepam produced behavioral and subjective anxiolysis in an experimental paradigm, consistent with mental relaxation.

PubMed ID: 28418172

Clobazam (a benzodiazepine) showed analgesic benefit in low-back pain likely linked to GABA-mediated muscle relaxation and antinociception.

PubMed ID: 30177236

Phase‑3 brexanolone trials replicate rapid symptomatic/mental relaxation effects.

PubMed ID: 29793605

ABP-700 produced predictable hypnotic/sedative effects useful for pre-sleep relaxation in experimental settings.

PubMed ID: 31712421

Brotizolam is an established GABAergic hypnotic used for pre-bedtime relaxation and sleep induction (with caveats about next-day impairment).

PubMed ID: 33443117

Gaboxadol reduced sleep‑onset latency substantially and improved sleep CGI measures — strong evidence for promoting relaxation at bedtime and faster sleep initiation.

PubMed ID: 33798307

Acupuncture reduced pre‑sleep arousal (PSAS) and improved sleep quality with increased serum GABA — strong support for pre‑bed relaxation.

PubMed ID: 35897310

SNK12 lowered negative mood and cortisol during stress testing — evidence of mental relaxation under challenge.

PubMed ID: 35348021

Acute diazepam altered hemodynamic indices consistent with sedation/relaxation — supports pharmacologic muscle relaxation.

PubMed ID: 36647565

Ciprofol (GABA‑acting anesthetic) produced effective perioperative immobility/relaxation — clinical demonstration of muscle relaxation in anesthesia context.

PubMed ID: 37242260

Nightly GABA associated with improved subjective sleep scores and sleepiness on rising, consistent with pre‑bed relaxation effect.

PubMed ID: 38201970

Yeast mannan increased fecal GABA and extended N3 sleep — supports a pre‑bedtime relaxation/sleep‑promoting pathway mediated by gut GABA.

PubMed ID: 39683592

Melissa officinalis phytosome reduced insomnia severity and increased deep sleep—supports pre‑bed relaxation/ritual benefits.

PubMed ID: 38325605

Zuranolone improved wellbeing and functioning in mood disorders, implying increased mental relaxation from GABA‑A potentiation.

PubMed ID: 38357797

SAGE‑324 (GABA‑A PAM) produced modest tremor reduction—evidence for reduced involuntary muscle activity / increased relaxation.

PubMed ID: 39302437

Zuranolone caused pronounced sleepiness and sedation—evidence it produces strong pre‑bed relaxation though with next‑day impairment risk.

PubMed ID: 39805976

Ciprofol (potent GABA‑A agonist) is an anesthetic producing profound central relaxation/muscle suppression in procedural contexts.

PubMed ID: 39777869

PSQI improvements and increased serum GABA after therapy imply better pre‑sleep relaxation.

PubMed ID: 40312029

Anxiety reductions from GABA‑producing probiotic are consistent with increased mental relaxation.

PubMed ID: 15820913

Pregabalin reduced sleep interference in diabetic neuropathy, implying easier falling asleep.

PubMed ID: 15082123

Pregabalin reduced sleep problems in PHN trial; likely facilitates sleep onset for sufferers.

PubMed ID: 12707429

Pregabalin improved sleep interference in PHN; supports easier sleep initiation as a secondary effect.

PubMed ID: 10666558

Midazolam causes marked sedation and amnesia — strong evidence that GABAergic agents promote sleep initiation (drug context).

PubMed ID: 9846778

Gabapentin reduced sleep interference in postherpetic neuralgia; supports improved sleep initiation.

PubMed ID: 9450157

Pivagabine improved sleep in patients with insomnia linked to mood disorders.

PubMed ID: 39970858

Lime peel supplement reduced sleep latency on PSG, indicating it helped sleep initiation likely via GABA_A activation.

PubMed ID: 37678556

Pregabalin improved secondary sleep measures in neuropathic pain patients, suggesting facilitation of sleep initiation for some users.

PubMed ID: 40760644

TEAS produced large ISI/PSQI improvements consistent with easier sleep onset.

PubMed ID: 38828963

Gabapentin markedly improved insomnia severity — likely eases sleep initiation in many.

PubMed ID: 26659543

GHB produced dose-related sedation—likely improves sleep onset acutely.

PubMed ID: 24983280

Pregabalin reduced sleep interference and improved sleep‑related outcomes in neuropathic pain patients.

PubMed ID: 24190578

Gabapentin produced dose‑related improvements in sleep measures, consistent with facilitating sleep onset in many patients.

PubMed ID: 21454917

Gabapentin added to naltrexone improved sleep quality during the first 6 weeks — supports easier sleep onset.

PubMed ID: 18855801

Gabapentin reduced arousal and improved sleep measures in alcohol‑dependent volunteers — facilitation of sleep onset likely.

PubMed ID: 39302437

Zuranolone produced pronounced sleepiness and sedative effects—strong evidence it facilitates sleep onset (but causes next‑day impairment).

PubMed ID: 39119911

Zolpidem‑ER improved early insomnia (sleep initiation) in depressed patients — pharmacologic GABAergic support for falling asleep.

PubMed ID: 39683592

Melissa officinalis phytosome reduced insomnia severity and increased deep sleep—plausible effect on sleep initiation/quality.

PubMed ID: 37242260

Nightly oral GABA improved sleep initiation/maintenance OSA Factor 2 vs baseline (subjective) though placebo effects present.

PubMed ID: 36194395

Dexmedetomidine markedly increased total sleep time/efficiency in ventilated ICU patients — strong facilitation of sleep onset/continuity (drug context).

PubMed ID: 33798307

Acupuncture improved PSQI and pre‑sleep arousal in insomnia patients with increased serum GABA — supports improved sleep initiation/quality.

PubMed ID: 33443117

Gaboxadol significantly reduced actigraphic sleep‑onset latency by ~25.7 minutes vs placebo (once‑daily dosing) — strong support for easier sleep initiation.

PubMed ID: 31712421

Brotizolam (GABA-A agonist) is an established hypnotic that promotes sleep onset (though with next-day impairments).

PubMed ID: 29793605

ABP-700 showed dose-dependent hypnotic onset and depth, indicating facilitation of sleep initiation under controlled conditions.

PubMed ID: 26872077

Eszopiclone increased total sleep time and efficiency — commonly aids sleep initiation clinically.

PubMed ID: 22002961

Gaboxadol reduced latency to persistent sleep (notably night‑1 effect) in randomized trial.

PubMed ID: 20191935

Gaboxadol shortened sleep onset time (sTSO) vs placebo in large RCTs.

PubMed ID: 19345644

EVT201 significantly reduced latency to persistent sleep in insomnia patients — direct evidence aiding sleep initiation.

PubMed ID: 19945340

EVT‑201 reduced latency to persistent sleep substantially in elderly insomnia — strong direct effect.

PubMed ID: 19346160

Gaboxadol significantly improved time‑to‑sleep onset (sTSO) in insomnia patients — direct evidence for easier sleep initiation.

PubMed ID: 19487320

Gaboxadol increased slow‑wave power and altered EEG conducive to sleep initiation/quality (mechanistic support).

PubMed ID: 18853933

Large 30‑night gaboxadol trials showed some reductions in sleep latency, though inconsistent/short‑lived.

PubMed ID: 17653697

Gaboxadol showed improvements in total sleep time and sleep onset measures in PSG studies (dose-dependent).

PubMed ID: 17765013

Gaboxadol had smaller but measurable effects on latency to persistent sleep and self‑reported time to sleep onset.

PubMed ID: 17561543

Indiplon reduced sleep latency and increased subjective total sleep time in elderly insomniacs (favors sleep initiation).

PubMed ID: 15536461

Triazolam produced sedation (acute hypnotic), supporting easier sleep initiation in the short term.

PubMed ID: 12128237

Clonazepam co-therapy with fluoxetine reduced insomnia and accelerated early symptomatic sleep improvement.

PubMed ID: 11471907

Zolpidem significantly improved self-rated sleep quality and reduced jet-lag-related sleep problems (helps sleep initiation/continuity).

PubMed ID: 11586699

Large trial reported zolpidem produced 'no difficulty falling asleep' in 59.5% and major improvements in falling-asleep metrics — strong clinical support for easier sleep initiation.

PubMed ID: 1363657

Zolpidem consistently shortens sleep onset latency (GABA‑A modulation) → strong evidence that GABAergic modulation aids falling asleep.

PubMed ID: 41554764

GABA‑producing probiotic improved insomnia severity and increased urinary GABA; supports easier sleep initiation.

PubMed ID: 39909068

Gabapentin enacarbil increased total sleep time and reduced nighttime wake, suggesting improved ability to maintain and possibly initiate sleep.

PubMed ID: 38803031

Gabapentin strongly increased total and slow‑wave sleep in ICU, consistent with facilitating sleep onset/continuity.

PubMed ID: 39158916

GABA‑analogue reduced pain and sleep interference in neuropathy — likely aids sleep initiation for symptomatic patients.

PubMed ID: 38321713

Oral GABA increased sleep efficiency; this commonly includes shorter sleep latency in practice (study showed sleep improvement overall).

PubMed ID: 38063320

Reduction in nocturnal cramps and insomnia scores suggests easier sleep initiation in affected patients.

PubMed ID: 35325767

rTMS increased DLPFC GABA and significantly improved ISI scores — supports GABA‑related improvements in initiating sleep (insomnia outcomes improved).

PubMed ID: 35615728

Pregabalin increased continuous sleep and improved sleep measures in PHN, suggesting easier sleep initiation/maintenance.

PubMed ID: 36327047

Combined auricular interventions increased GABA and melatonin and improved insomnia measures — supports easier sleep onset.

PubMed ID: 34259401

Acupuncture raised serum GABA and improved PSQI, suggesting facilitation of sleep initiation.

PubMed ID: 32886447

Pregabalin improved sleep metrics in fibromyalgia which can include sleep onset improvements.

PubMed ID: 32936427

Trazodone added to gabapentin improved sleep measures, which commonly includes sleep initiation improvements.

PubMed ID: 31354243

Pregabalin reduced sleep interference in neuropathic pain patients, consistent with facilitating sleep onset for some.

PubMed ID: 29078970

Acupuncture + gabapentin improved PSQI in restless legs, implying easier sleep onset for some patients.

PubMed ID: 25968451

Pregabalin improved sleep interference in DPN, consistent with easier sleep initiation for sufferers.

PubMed ID: 27037091

Extended‑release gabapentin reduced pain-associated sleep interference; may shorten time to fall asleep in symptomatic patients.

PubMed ID: 26035523

Pregabalin improved sleep consolidation; latency less directly measured but overall sleep quality improved.

PubMed ID: 26160608

Reduced hot-flash/night-sweat severity with gabapentin likely helps initial sleep onset in menopausal women.

PubMed ID: 25272094

Pregabalin produced rapid improvements in sleep interference (mean time to sustained improvement ≈1.6 days), consistent with easier sleep onset for many patients.

PubMed ID: 26123629

Gabapentin produced improvements in insomnia severity comparable to clonazepam.

PubMed ID: 25874578

RLS treatment reduced sleep disturbance, likely making sleep onset easier for many patients.

PubMed ID: 26115203

G‑GR reduced sleep interference in PHN, implying improved sleep onset/continuity.

PubMed ID: 26714731

Pregabalin improved sleep interference in PHN patients, consistent with easier sleep onset/maintenance.

PubMed ID: 25530068

Pregabalin improved sleep measures in cancer patients, consistent with easier sleep initiation.

PubMed ID: 25099523

Pruritus relief improved sleep in dialysis patients, likely easing sleep onset.

PubMed ID: 24899755

Pregabalin reduced awakenings and increased slow-wave sleep in RLS; likely helps with sleep initiation.

PubMed ID: 24521108

RLS symptom relief helps patients fall asleep more easily.

PubMed ID: 25317091

Gabapentin increased total sleep time and reduced WASO; likely also aided sleep initiation.

PubMed ID: 24149930

Gabapentin reduced sleep interference from hot flashes — likely eases sleep initiation for some.

PubMed ID: 23121149

Gabapentin enacarbil reduced RLS symptoms that commonly impair sleep onset—likely helps falling asleep for many RLS sufferers.

PubMed ID: 23062189

Pregabalin improved sleep quality in fibromyalgia, which commonly includes difficulty falling asleep.

PubMed ID: 21611981

Gabapentin enacarbil reduced wake time during sleep and PLMs with arousal; supports easier sleep initiation/maintenance.

PubMed ID: 21627766

Gabapentin enacarbil improved reported sleep in PHN, implying easier sleep.

PubMed ID: 21397402

Sodium oxybate improved sleep disturbance in fibromyalgia — promotes consolidated sleep.

PubMed ID: 20236172

Pregabalin trial demonstrated improvements in sleep-related measures, implying easier sleep in that patient population.

PubMed ID: 20511481

Gabapentin enacarbil maintenance reduced RLS relapse and supports improved sleep initiation/continuity in RLS patients.

PubMed ID: 19238802

Gabapentin prodrug for RLS improved symptoms and sleep stages, facilitating sleep onset.

PubMed ID: 19410509

Pregabalin improved several sleep measures including those consistent with easier sleep initiation.

PubMed ID: 19534799

Pregabalin trials reported improved sleep quality and diary measures implying easier sleep onset.

PubMed ID: 19667976

RLS improvement with gabapentin enacarbil is likely to ease sleep onset for patients with leg restlessness.

PubMed ID: 19415540

Gabapentin improved sleep quality in hot‑flash sufferers and is known to reduce sleep latency in some contexts.

PubMed ID: 18524684

Pregabalin improved sleep measures in fibromyalgia, including aspects related to sleep onset in some patients.

PubMed ID: 17631400

Pregabalin improved sleep interference, consistent with easier sleep initiation for some patients.

PubMed ID: 17130411

Pregabalin reduced sleep interference in central neuropathic pain, consistent with easier falling asleep.

PubMed ID: 16466610

Pregabalin improved sleep-interference scores in PHN; this supports easier sleep onset as part of sleep benefit.

PubMed ID: 15818684

Improved sleep quality in fibromyalgia likely includes easier sleep onset for many patients.

PubMed ID: 21350425

Pantogam improved anxiety and quality-of-life scores in add-on trial — directly supports mood balance.

PubMed ID: 27808555

Baclofen-treated alcohol-dependent patients showed reduced craving/anxiety and longer abstinence (open-label RCT).

PubMed ID: 26892006

Pregabalin+paroxetine reduced somatic and depressive symptoms in fibromyalgia.

PubMed ID: 26048580

Individually‑titrated high‑dose baclofen produced large abstinence gains; abstinence often linked with improved mood/wellbeing.

PubMed ID: 24983280

Pregabalin reduced pain‑related mood and sleep interference in neuropathic pain (supports mood/work effect).

PubMed ID: 24190578

Gabapentin RCT showed dose‑related improvement in depression/craving scores (supports mood benefit).

PubMed ID: 22302014

Pregabalin produced clear, clinically meaningful anxiety/mood improvements in GAD (direct evidence for mood stabilizing/anxiolytic benefit).

PubMed ID: 21454917

Gabapentin added to naltrexone improved early abstinence and sleep, which can stabilize mood in those patients.

PubMed ID: 21456104

Large pregabalin RCT in GAD showed meaningful anxiolytic/mood benefits consistent with better mood balance.

PubMed ID: 18068515

Baclofen increased abstinence and improved clinical outcomes in alcohol dependence, plausibly improving mood stability.

PubMed ID: 16841627

Pregabalin (GABAergic anticonvulsant) produced significant anxiety improvement, which supports mood stabilisation.

PubMed ID: 14624703

Baclofen reduced depressive symptoms and withdrawal-related mental symptoms in opioid-dependent patients.

PubMed ID: 12217947

Baclofen increased abstinence and reduced craving and state anxiety (supports mood stabilization).

PubMed ID: 9311358

Divalproex reduced migraine burden and has mood-stabilizing properties (indirect support for mood-smoothing).

PubMed ID: 8261880

Baclofen produced clear anxiolytic/antidepressant effects in alcoholic patients (strong support).

PubMed ID: 26978493

Pantogam activ produced rapid reductions in anxiety and cognitive symptoms in hypertensive patients.

PubMed ID: 34155332

Baclofen 90 mg/day reduced heavy drinking and produced anxiolytic effects in high-anxiety subgroup—direct evidence for mood stabilization in AUD.

PubMed ID: 40760644

TEAS RCT increased serum GABA and produced large improvements in anxiety/depression scores.

PubMed ID: 26506383

Six months adjunctive sarcosine significantly improved clinical symptoms in schizophrenia with large spectroscopic Glx/NAA changes, consistent with mood/psychopathology benefits.

PubMed ID: 39112627

Daily phototherapy increased plasma GABA and produced substantial HAMD/depression improvements, directly linking raised GABA to mood benefits.

PubMed ID: 37875578

Zuranolone (GABA_A PAM) co‑initiated with ADT produced rapid, modest antidepressant effects, supporting GABAergic impact on mood.

PubMed ID: 8788983

Baclofen produced clinical improvement on affective/psychosemantic measures in alcoholic patients—direct mood effect.

PubMed ID: 9450156

Pivagabine improved anxiety and mild depression in climacteric women (controlled trial).

PubMed ID: 9450158

Open trial reported sizable improvements in depression/anxiety with pivagabine.

PubMed ID: 10372564

Multisite trial reported improvements in emotional/interpersonal adjustment (direct mood-related outcome).

PubMed ID: 11690735

Gabapentin improved sleep and global patient ratings in PHN, which commonly relates to improved mood balance.

PubMed ID: 12611835

Pregabalin produced significant short‑term anxiety score reductions, relevant to mood regulation.

PubMed ID: 12826986

Rapid, significant anxiety reduction with pregabalin supports mood‑stabilizing effect.

PubMed ID: 15206660

Pregabalin produced anxiolytic effects in social anxiety disorder, supporting mood/anxiety modulation.

PubMed ID: 15818684

Fibromyalgia trial showed reduced pain and improved sleep/fatigue that can improve mood.

PubMed ID: 16143734

Pregabalin reduced overall and psychic anxiety in GAD, supporting mood balance.

PubMed ID: 15738746

Large pregabalin RCT produced rapid, clinically meaningful anxiety score reductions — directly relevant to mood balance.

PubMed ID: 18090504

Pregabalin continuation significantly reduced relapse of generalized anxiety disorder (supports mood/anxiety stabilization).

PubMed ID: 18978320

Pregabalin produced statistically significant reductions in anxiety and depressive symptoms in elderly GAD patients.

PubMed ID: 19798503

Large real‑world pregabalin cohort produced clinically meaningful improvements in depression/anxiety (HADS).

PubMed ID: 20722471

Randomized trial: yoga increased thalamic GABA and correlated strongly with improved mood and reduced anxiety.

PubMed ID: 20347225

Meta-analysis: larger pain reductions associated with improvements across mood domains.

PubMed ID: 21397402

Sodium oxybate (GHB) improved sleep and fatigue in fibromyalgia with global symptom improvements; implies mood-related benefit.

PubMed ID: 21368587

Pregabalin 600 mg produced clinically meaningful reductions in social anxiety scores — supports mood/stability benefits (indirect for dietary GABA).

PubMed ID: 21627766

Gabapentin enacarbil improved PHN pain and reported sleep/mood vs placebo (direct mood benefit reported).

PubMed ID: 21316855

Pregabalin produced statistically significant improvements in anxiety (HADS‑A) and sleep in post‑stroke patients.

PubMed ID: 22203366

Acute oral GABA improved mood (POMS) during mental tasks.

PubMed ID: 23053645

Large RCT: gabapentin reduced anxiety scores in breast cancer survivors, supporting mood stabilization.

PubMed ID: 22993294

Arbaclofen (GABA‑B agonist) showed subgroup improvements in social/behavioral domains—signals for mood/behavior balance.

PubMed ID: 23059159

BL‑1020 showed clinical benefit on psychosis and global impression, consistent with mood/affect improvements.

PubMed ID: 22644743

Gabapentin and pregabalin improved depression (BDI) in hemodialysis patients—direct mood benefit.

PubMed ID: 22978083

Adjunctive gabapentin improved mania scores vs lithium alone (clinical psychiatric effect on mood dysregulation).

PubMed ID: 25406046

Pregabalin augmentation modestly reduced PTSD symptom severity, indicating mood/stress symptom improvement.

PubMed ID: 25317091

Marked sleep improvements are likely to reduce mood instability from sleep deprivation.

PubMed ID: 24521108

RLS symptom improvement and better sleep can reduce nocturnal-triggered mood swings.

PubMed ID: 24899755

Pregabalin improved sleep architecture in RLS — this likely contributes to smoother moods.

PubMed ID: 25099523

Pruritus relief and improved sleep in dialysis patients likely smooth mood variability.

PubMed ID: 24525635

Baclofen added to citalopram improved PTSD symptoms (including hyperarousal/avoidance) in humans — supports mood symptom improvement.

PubMed ID: 26034150

Pregabalin reduced anxiety (HADS‑A) in fibromyalgia, indicating improved mood balance.

PubMed ID: 25874578

Gabapentin enacarbil for RLS improved mood measures alongside symptom reduction.

PubMed ID: 27067343

Pooled RCTs of gabapentin enacarbil in RLS showed improvements on multiple mood (POMS) factors.

PubMed ID: 25756560

Pregabalin in fibromyalgia improved symptoms including some mood measures in large pooled data.

PubMed ID: 27070434

Gabapentin reduced anxiety scores in chronic pelvic pain trial (signal for mood/anxiety benefit).

PubMed ID: 27939574

Perioperative pregabalin improved emotional state on QoR‑40 (better postoperative mood/comfort).

PubMed ID: 27500873

Pregabalin improved mood/anxiety and retention during opioid withdrawal in a randomized trial.

PubMed ID: 28488610

Pregabalin improved HAD scores (~80% improvement reported) in central poststroke pain trial—signal for mood benefit.

PubMed ID: 30980177

Baclofen (GABA‑B agonist) added to risperidone improved behavioral domains in ASD including hyperactivity/irritability.

PubMed ID: 31648655

Large randomized trial: pregabalin augmentation produced major reductions in OCD severity — a robust mood/anxiety-related benefit.

PubMed ID: 33180985

Early vigabatrin reduced seizures and long-term epilepsy burden in infants — likely to improve mood/overall mental health indirectly.

PubMed ID: 32066666

Bumetanide in young children reduced GABA/Glx ratios and improved autism severity scores (mechanistic + clinical).

PubMed ID: 36654288

Bumetanide lowered insular GABA and improved core autism symptoms including emotional/behavioral measures (clinically meaningful RCT).

PubMed ID: 33710299

Direct multimodal human evidence linking cortical GABA deficits to altered frontal connectivity and cognition — mechanistic support for mood regulation.

PubMed ID: 36104745

Pregabalin+agomelatine produced clear improvements on mental‑health scales (GHQ‑28/HADS) vs pregabalin alone.

PubMed ID: 37068811

Acupuncture + low‑frequency rTMS altered serum GABA and improved depression scores and sleep in depressed/insomniac patients (multi‑modal intervention but mood improved).

PubMed ID: 38321713

200 mg/day oral GABA for 90 days reduced depressive symptoms and improved emotional measures in RCT — strong direct support for mood effects.

PubMed ID: 39163908

GABA‑producing probiotic decreased negative cognitive reactivity and rumination in mildly stressed adults — supports mood stabilization.

PubMed ID: 40016875

Pregabalin used as augmentation improved pain and mood in treatment‑resistant burning mouth syndrome (clinical mood effects).

PubMed ID: 40311814

dACC Glx/GABA ratio predicted ketamine antidepressant response — direct mechanistic link between cortical GABA balance and mood change.

PubMed ID: 40199850

Changes in regional GABAergic markers after brain stimulation associated with clinical improvement in depression (mechanistic evidence).

PubMed ID: 40663563

Combination product containing 50 mg GABA reduced stress/anxiety and hot‑flash measures (cannot attribute solely to GABA).

PubMed ID: 35851507

High‑dose vitamin B6 reduced anxiety and increased measures consistent with enhanced GABAergic inhibition (indirectly supports mood stabilization).

PubMed ID: 10520979

Clonazepam (GABA‑A agent) reduced panic and improved global clinical ratings — strong clinical evidence that GABAergic modulation relieves acute anxiety-related mood disturbance.

PubMed ID: 12700707

Alprazolam strongly blunted experimentally induced panic and HPA responses (relevant to mood/anxiety balance).

PubMed ID: 12870055

Clonazepam produced clear reductions in panic and anxiety in panic disorder — supports stabilization of mood/anxiety.

PubMed ID: 14658975

Tiagabine produced anxiety and sleep improvements in GAD (open-label), consistent with mood-stabilizing effects.

PubMed ID: 17476705

Open‑label tiagabine study reported clinical improvement in social anxiety measures (mood/stability signal, uncontrolled).

PubMed ID: 20041911

Ocinaplon (GABA(A) modulator) produced large anxiolytic/HAM‑A improvements — direct mood‑balancing evidence for GABA‑A modulation.

PubMed ID: 23635869

6‑week RCT: kava significantly reduced anxiety (HAM‑A) — supports mood stabilization in anxious subjects.

PubMed ID: 23348009

Pregnenolone raised allopregnanolone ~7× and reduced amygdala/insula activation while enhancing prefrontal regulation — mechanistic support for mood balance.

PubMed ID: 28319848

Sepranolone (GABA‑modulating steroid antagonist) significantly reduced PMDD symptom scores (per‑protocol subgroup) — direct, clinically meaningful mood effect.

PubMed ID: 30177236

Phase‑3 brexanolone trials (GABAAR PAM) produced rapid, clinically meaningful reductions in postpartum depression scores — strong direct evidence for mood benefit.

PubMed ID: 34256607

Gabapentin-modulated dACC glutamate/GABA related to subsequent abstinence, suggesting neurochemical mood-relevant effects.

PubMed ID: 31483961

SAGE-217 (oral GABA-A PAM) produced robust, rapid antidepressant effects in major depression (direct support for mood benefit).

PubMed ID: 34190962

Zuranolone (oral GABA‑A PAM) produced rapid, clinically meaningful and sustained antidepressant and anxiolytic effects in postpartum depression — strong direct evidence for mood benefit from GABAergic modulation.

PubMed ID: 34597899

Sepranolone targeted GABA‑A steroid modulation in PMDD and reduced distress with some improved symptom metrics — directly relevant to mood‑swing stabilization in PMDD.

PubMed ID: 37491938

Zuranolone (GABA-A PAM) produced clinically meaningful antidepressant effects in postpartum depression — strong, direct mood benefit.

PubMed ID: 37132201

Zuranolone in MDD gave early symptom improvement vs placebo (moderate clinical evidence for mood benefit).

PubMed ID: 37366077

Zuranolone (GABA‑A modulator) is a mood‑targeted agent; phase‑1 EEG signal supports potential mood effects.

PubMed ID: 38325605

Zuranolone (GABA‑A PAM) produced robust, clinically meaningful improvements in SF‑36 functioning/wellbeing in mood disorders (direct GABAergic mood benefit).

PubMed ID: 40312029

GABA‑producing probiotic significantly reduced anxiety scores, consistent with improved mood balance.

PubMed ID: 25403296

Open‑label noofen study reported better attention and memory in children — uncontrolled but relevant to concentration.

PubMed ID: 26227783

Randomized oral GABA in humans produced large, significant improvements in action selection and inhibition (faster RTs/SSRT) — direct cognitive focus evidence.

PubMed ID: 30008787

RDBPC trial of a GABA‑enriched supplement showed objective cognitive test improvements (K‑MMSE, numerical memory, Raven).

PubMed ID: 12516410

Flumazenil rapidly restored consciousness/alertness in benzodiazepine overdose—direct improvement in focus in that context.

PubMed ID: 16676776

Tiagabine prevented sustained-attention deficits during sleep restriction (PVT), indicating preserved/better concentration under stress.

PubMed ID: 34732523

GABA agonism increased neural variability and improved performance especially in poorer‑performing older adults — translates to better concentration/cognitive function.

PubMed ID: 22993919

Hopantenic acid reduced early postoperative cognitive dysfunction in children — implying better concentration early post-op.

PubMed ID: 26978493

Pantogam activ reduced cognitive symptoms in hypertensive patients, often early, supporting improved focus.

PubMed ID: 31793540

Pantogam improved psychomotor development in preterm infants, consistent with attentional/processing gains.

PubMed ID: 21631542

Gabapentin+flumazenil improved response inhibition (domain of attention/concentration) in higher‑AW patients.

PubMed ID: 39317299

Multi‑ingredient supplement improved some cognitive tests and modestly increased GABA.

PubMed ID: 37630690

Functional soup improved attention and working memory accuracy.

PubMed ID: 21350425

Pantogam improved memory and anxiety as add-on, which can support better focus indirectly.

PubMed ID: 15451390

SGS742 (GABAB antagonist) RCT improved attention in MCI — direct cognitive/GABAergic signal supporting focus.

PubMed ID: 1940126

Vigabatrin group showed significant improvements in sustained concentration and flexible mental processing after 3 months.

PubMed ID: 9450159

Pivagabine reduced fatigability and improved global status, supporting concentration gains.

PubMed ID: 9450160

Pivagabine improved attention/motor activity in children (randomized study).

PubMed ID: 11407953

Carer-rated improvements in attention with gabapentin (direct evidence supportive of improved concentration).

PubMed ID: 15774213

Seizure control and MMSE improvements suggest better concentration in treated patients.

PubMed ID: 23059159

BL‑1020 improved cognition (BACS composite) — supports better concentration.

PubMed ID: 22373942

Gabapentin improved executive function in cannabis‑dependent adults—supports better focus/concentration.

PubMed ID: 25317091

Marked sleep improvements likely translate to better daytime concentration.

PubMed ID: 24899755

Objective sleep improvements in RLS likely to produce substantial concentration gains.

PubMed ID: 20006256

Intrathecal baclofen decreased immediate opioid needs and reduced chronic pain incidence — supports recovery trajectory.

PubMed ID: 17450066

Gabapentin improved walking distance and function in lumbar stenosis, suggesting faster functional recovery potential.

PubMed ID: 16368826

Gabapentin reduced postoperative pain and opioid needs and aided recovery after hysterectomy—supports faster functional recovery post-insult.

PubMed ID: 16244006

Perioperative gabapentin reduced opioid use and improved early recovery metrics; analogous benefits could translate to faster recovery in other contexts.

PubMed ID: 15845693

Gabapentin reduced opioid needs and improved early knee flexion after ACL repair—faster early recovery signal.

PubMed ID: 36554328

Fermented sarco oyster (GABA precursors) produced modest increases in quadriceps and handgrip strength and IGF‑1 — suggests functional recovery/rehab benefit.

PubMed ID: 30008787

GABA‑enriched supplement improved physical function (6MW, TUG) and increased IGF‑1/BDNF—consistent with improved recovery/physical capacity.

PubMed ID: 19727980

Single preop pregabalin dose halved 24‑h morphine use and improved pain/nausea — aided early recovery.